{
    "5e2b109cfbd6abf43b000002": [
        {
            "text": "Length of stay, Acuity of admission",
            "probability": 0.15134473065897075,
            "start_logit": 5.369505405426025,
            "end_logit": 5.161472797393799,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co-morbidities and Emergency department visits",
            "probability": 0.15005336217881937,
            "start_logit": 5.369505405426025,
            "end_logit": 5.1529035568237305,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co-morbidities",
            "probability": 0.1333320524565703,
            "start_logit": 5.369505405426025,
            "end_logit": 5.034755229949951,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay",
            "probability": 0.13081990646951788,
            "start_logit": 5.369505405426025,
            "end_logit": 5.0157341957092285,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Co-morbidities and Emergency department visits",
            "probability": 0.08144702188699232,
            "start_logit": 4.758467197418213,
            "end_logit": 5.1529035568237305,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Co-morbidities",
            "probability": 0.07237091150098036,
            "start_logit": 4.758467197418213,
            "end_logit": 5.034755229949951,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Emergency department visits",
            "probability": 0.06762909259058189,
            "start_logit": 4.572552680969238,
            "end_logit": 5.1529035568237305,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission",
            "probability": 0.06375640886674393,
            "start_logit": 4.505014896392822,
            "end_logit": 5.161472797393799,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission, Co-morbidities and Emergency department visits",
            "probability": 0.06321239906567802,
            "start_logit": 4.505014896392822,
            "end_logit": 5.1529035568237305,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission, Co-morbidities",
            "probability": 0.05616827764303384,
            "start_logit": 4.505014896392822,
            "end_logit": 5.034755229949951,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity",
            "probability": 0.014966291148877407,
            "start_logit": 5.369505405426025,
            "end_logit": 2.847712993621826,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity",
            "probability": 0.006304791541482054,
            "start_logit": 4.505014896392822,
            "end_logit": 2.847712993621826,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length",
            "probability": 0.002108648707589442,
            "start_logit": 5.369505405426025,
            "end_logit": 0.887959897518158,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission,",
            "probability": 0.0016104409488308905,
            "start_logit": 5.369505405426025,
            "end_logit": 0.6184206008911133,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay,",
            "probability": 0.0011500434399058655,
            "start_logit": 5.369505405426025,
            "end_logit": 0.28171229362487793,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Length of stay, Acuity of admission, Co",
            "probability": 0.0009645708639661939,
            "start_logit": 5.369505405426025,
            "end_logit": 0.10584060102701187,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission",
            "probability": 0.0007250347029520165,
            "start_logit": 0.028409427031874657,
            "end_logit": 5.161472797393799,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission, Co-morbidities and Emergency department visits",
            "probability": 0.0007188482506167984,
            "start_logit": 0.028409427031874657,
            "end_logit": 5.1529035568237305,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "Acuity of admission,",
            "probability": 0.0006784242248960209,
            "start_logit": 4.505014896392822,
            "end_logit": 0.6184206008911133,
            "question_text": "What is included in the LACE Index?"
        },
        {
            "text": "admission, Co-morbidities",
            "probability": 0.0006387428529947444,
            "start_logit": 0.028409427031874657,
            "end_logit": 5.034755229949951,
            "question_text": "What is included in the LACE Index?"
        }
    ],
    "5e2f906ffbd6abf43b00002c": [
        {
            "text": "ibuprofen",
            "probability": 0.2663186121301735,
            "start_logit": 5.072861194610596,
            "end_logit": 4.7682600021362305,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol and ibuprofen",
            "probability": 0.24877053881061167,
            "start_logit": 5.004698753356934,
            "end_logit": 4.7682600021362305,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol",
            "probability": 0.2122948074562373,
            "start_logit": 5.004698753356934,
            "end_logit": 4.609704971313477,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol, THC and ibuprofen",
            "probability": 0.20303110840416708,
            "start_logit": 5.00183629989624,
            "end_logit": 4.56795072555542,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "ibuprofen) exited the stomach much earlier than the lipophilic cannabinoids",
            "probability": 0.021536959907181692,
            "start_logit": 5.072861194610596,
            "end_logit": 2.2533371448516846,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol and ibuprofen) exited the stomach much earlier than the lipophilic cannabinoids",
            "probability": 0.020117862126111257,
            "start_logit": 5.004698753356934,
            "end_logit": 2.2533371448516846,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "THC and ibuprofen",
            "probability": 0.011957386205231716,
            "start_logit": 2.1698262691497803,
            "end_logit": 4.56795072555542,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol, THC",
            "probability": 0.00648516355558094,
            "start_logit": 5.00183629989624,
            "end_logit": 1.1241085529327393,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "cannabinoids",
            "probability": 0.0030811274621768492,
            "start_logit": 3.1283862590789795,
            "end_logit": 2.2533371448516846,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "ibuprofen)",
            "probability": 0.002543540835794902,
            "start_logit": 5.072861194610596,
            "end_logit": 0.11712376028299332,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol and ibuprofen)",
            "probability": 0.002375943683193297,
            "start_logit": 5.004698753356934,
            "end_logit": 0.11712376028299332,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "cannabidiol",
            "probability": 0.0005433011559843778,
            "start_logit": 2.088331937789917,
            "end_logit": 1.558004379272461,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "THC",
            "probability": 0.00038193952566031224,
            "start_logit": 2.1698262691497803,
            "end_logit": 1.1241085529327393,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "met",
            "probability": 0.00017485244199513442,
            "start_logit": 5.00183629989624,
            "end_logit": -2.4892213344573975,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "fen",
            "probability": 7.676337668049482e-05,
            "start_logit": -3.078859806060791,
            "end_logit": 4.7682600021362305,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol, THC and i",
            "probability": 6.852676799462985e-05,
            "start_logit": 5.00183629989624,
            "end_logit": -3.4259393215179443,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "i",
            "probability": 6.507168564436947e-05,
            "start_logit": 4.950101375579834,
            "end_logit": -3.4259393215179443,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "ibuprofen) exited the stomach much earlier than the lipophilic can",
            "probability": 6.195768084129615e-05,
            "start_logit": 5.072861194610596,
            "end_logit": -3.5977370738983154,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol and ibuprofen) exited the stomach much earlier than the lipophilic can",
            "probability": 5.787521015921838e-05,
            "start_logit": 5.004698753356934,
            "end_logit": -3.5977370738983154,
            "question_text": "Which drugs are included in GI cocktail?"
        },
        {
            "text": "metoprolol and i",
            "probability": 5.6661578579815004e-05,
            "start_logit": 5.004698753356934,
            "end_logit": -3.618929862976074,
            "question_text": "Which drugs are included in GI cocktail?"
        }
    ],
    "5e48136dd14c9f295d000008": [
        {
            "text": "embryonic fibroblasts",
            "probability": 0.4479837310392817,
            "start_logit": 3.6592307090759277,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd mouse embryonic fibroblasts",
            "probability": 0.1339352023325744,
            "start_logit": 2.4518299102783203,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "fibroblasts",
            "probability": 0.11557404343621572,
            "start_logit": 2.304385185241699,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "mouse embryonic fibroblasts",
            "probability": 0.0953194058098988,
            "start_logit": 2.1117072105407715,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "embryonic fibroblasts (MEFs)",
            "probability": 0.05885656064622112,
            "start_logit": 3.6592307090759277,
            "end_logit": 0.7239744067192078,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "embryonic fibroblast",
            "probability": 0.05082066930442296,
            "start_logit": 3.6592307090759277,
            "end_logit": 0.5771742463111877,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd mouse embryonic fibroblasts (MEFs)",
            "probability": 0.017596543830873713,
            "start_logit": 2.4518299102783203,
            "end_logit": 0.7239744067192078,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd mouse embryonic fibroblast",
            "probability": 0.015194026377194251,
            "start_logit": 2.4518299102783203,
            "end_logit": 0.5771742463111877,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "fibroblasts (MEFs)",
            "probability": 0.015184236000829594,
            "start_logit": 2.304385185241699,
            "end_logit": 0.7239744067192078,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "fibroblast",
            "probability": 0.013111079342146708,
            "start_logit": 2.304385185241699,
            "end_logit": 0.5771742463111877,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "mouse embryonic fibroblasts (MEFs)",
            "probability": 0.01252316099916615,
            "start_logit": 2.1117072105407715,
            "end_logit": 0.7239744067192078,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "mouse embryonic fibroblast",
            "probability": 0.010813330184381614,
            "start_logit": 2.1117072105407715,
            "end_logit": 0.5771742463111877,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "embryonic fibroblasts (MEFs) showed lower levels of recruitment of HR factors, Rad51",
            "probability": 0.0023810615197516587,
            "start_logit": 3.6592307090759277,
            "end_logit": -2.4835824966430664,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "nic fibroblasts",
            "probability": 0.0023186121907663305,
            "start_logit": -1.6045573949813843,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "embryonic",
            "probability": 0.0022438107515790734,
            "start_logit": 3.6592307090759277,
            "end_logit": -2.5429532527923584,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd",
            "probability": 0.0017029210177683972,
            "start_logit": 2.4518299102783203,
            "end_logit": -1.611383080482483,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "em",
            "probability": 0.0014862030571104162,
            "start_logit": 3.6592307090759277,
            "end_logit": -2.954904317855835,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "ryonic fibroblasts",
            "probability": 0.0012054555519592494,
            "start_logit": -2.2586686611175537,
            "end_logit": 2.7536280155181885,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "embryonic fi",
            "probability": 0.0010791069630534716,
            "start_logit": 3.6592307090759277,
            "end_logit": -3.2749950885772705,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        },
        {
            "text": "129S2/SvHsd mouse embryonic",
            "probability": 0.000670839644804863,
            "start_logit": 2.4518299102783203,
            "end_logit": -2.5429532527923584,
            "question_text": "Which cells are affected in radiation-induced leukemias?"
        }
    ],
    "5e482160d14c9f295d00000c": [
        {
            "text": "antioxidant activity",
            "probability": 0.114079942535147,
            "start_logit": -2.8819377422332764,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.08829156191737263,
            "start_logit": -3.138192653656006,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.07192477462461608,
            "start_logit": -3.3432164192199707,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.06475934259420833,
            "start_logit": -3.4481592178344727,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study,",
            "probability": 0.056743556568265775,
            "start_logit": -3.3432164192199707,
            "end_logit": -3.1880180835723877,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "activity",
            "probability": 0.054280149186229976,
            "start_logit": -3.624678611755371,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.054279191531370806,
            "start_logit": -3.6246962547302246,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study,",
            "probability": 0.05109053784313862,
            "start_logit": -3.4481592178344727,
            "end_logit": -3.1880180835723877,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": ", the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.048344454819268724,
            "start_logit": -3.740485668182373,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "Enzymatic hydrolysis has been employed to modify protein functional properties and discover new sources of antioxidants. In this study,",
            "probability": 0.046080651418280924,
            "start_logit": -3.551365375518799,
            "end_logit": -3.1880180835723877,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "study",
            "probability": 0.0444504788669424,
            "start_logit": -3.3432164192199707,
            "end_logit": -3.4321844577789307,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study,",
            "probability": 0.04282244040686853,
            "start_logit": -3.6246962547302246,
            "end_logit": -3.1880180835723877,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidants. In this study",
            "probability": 0.04002214542130456,
            "start_logit": -3.4481592178344727,
            "end_logit": -3.4321844577789307,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": ",",
            "probability": 0.03814035318311971,
            "start_logit": -3.740485668182373,
            "end_logit": -3.1880180835723877,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "Enzymatic hydrolysis has been employed to modify protein functional properties and discover new sources of antioxidants. In this study",
            "probability": 0.03609761435342891,
            "start_logit": -3.551365375518799,
            "end_logit": -3.4321844577789307,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.03502656882605617,
            "start_logit": -4.062730312347412,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "In this study",
            "probability": 0.03354527099559606,
            "start_logit": -3.6246962547302246,
            "end_logit": -3.4321844577789307,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "antioxidant",
            "probability": 0.028211699762108126,
            "start_logit": -2.8819377422332764,
            "end_logit": -4.34810209274292,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "enzymatic treatments on antioxidant activity",
            "probability": 0.027669796124743438,
            "start_logit": -4.298495769500732,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        },
        {
            "text": "this study, the effect of different enzymatic treatments on antioxidant activity",
            "probability": 0.024139469021933344,
            "start_logit": -4.434988975524902,
            "end_logit": -2.950939416885376,
            "question_text": "List five proteins with antioxidant properties?"
        }
    ],
    "5c72c9207c78d6947100007b": [
        {
            "text": "microarray",
            "probability": 0.10049068124483693,
            "start_logit": -3.0131723880767822,
            "end_logit": -4.420410633087158,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic",
            "probability": 0.08274930436133114,
            "start_logit": -4.038863658905029,
            "end_logit": -3.5889687538146973,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation methods",
            "probability": 0.06441139832035447,
            "start_logit": -4.7075934410095215,
            "end_logit": -3.1707639694213867,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation method",
            "probability": 0.06267722349468227,
            "start_logit": -3.834449529647827,
            "end_logit": -4.071200370788574,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray image analysis",
            "probability": 0.05947275901524154,
            "start_logit": -3.0131723880767822,
            "end_logit": -4.944957256317139,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic",
            "probability": 0.057396880469997594,
            "start_logit": -4.404689311981201,
            "end_logit": -3.5889687538146973,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray image analysis in a study of a metabolic disorder in yeast,",
            "probability": 0.05656111462791263,
            "start_logit": -3.0131723880767822,
            "end_logit": -4.995153903961182,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segmentation",
            "probability": 0.05504447713095883,
            "start_logit": -3.834449529647827,
            "end_logit": -4.201056957244873,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a fully automatic",
            "probability": 0.05304735392077302,
            "start_logit": -4.483494281768799,
            "end_logit": -3.5889687538146973,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic segmentation method",
            "probability": 0.05108975514643103,
            "start_logit": -4.038863658905029,
            "end_logit": -4.071200370788574,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "microarray image analysis in a study of a metabolic disorder in yeast, where replicates of reporters are present.",
            "probability": 0.04589409225400431,
            "start_logit": -3.0131723880767822,
            "end_logit": -5.204139232635498,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "fully automatic segmentation",
            "probability": 0.04486811479488407,
            "start_logit": -4.038863658905029,
            "end_logit": -4.201056957244873,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "methods",
            "probability": 0.03916160217171934,
            "start_logit": -5.2051873207092285,
            "end_logit": -3.1707639694213867,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "micro",
            "probability": 0.038447692602306446,
            "start_logit": -3.0131723880767822,
            "end_logit": -5.381176948547363,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic segmentation method",
            "probability": 0.0354370661120803,
            "start_logit": -4.404689311981201,
            "end_logit": -4.071200370788574,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a fully automatic segmentation method",
            "probability": 0.03275165083133715,
            "start_logit": -4.483494281768799,
            "end_logit": -4.071200370788574,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "state-of-the-art segmentation methods",
            "probability": 0.03151366025742287,
            "start_logit": -5.4224629402160645,
            "end_logit": -3.1707639694213867,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "automatic segmentation",
            "probability": 0.031121588775549006,
            "start_logit": -4.404689311981201,
            "end_logit": -4.201056957244873,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "segment",
            "probability": 0.029100384781457343,
            "start_logit": -3.834449529647827,
            "end_logit": -4.838447093963623,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        },
        {
            "text": "a fully automatic segmentation",
            "probability": 0.028763199686719396,
            "start_logit": -4.483494281768799,
            "end_logit": -4.201056957244873,
            "question_text": "Which methods are used for genome segmentation of gene expression data?"
        }
    ],
    "5e369ecfb5b409ea53000002": [
        {
            "text": "Transcribed ultraconserved regions",
            "probability": 0.6186527968899145,
            "start_logit": -1.6922130584716797,
            "end_logit": -1.7896993160247803,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565",
            "probability": 0.0584604608105532,
            "start_logit": -2.3163652420043945,
            "end_logit": -3.524740695953369,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs) are a subgroup of lncRNAs",
            "probability": 0.04985809987809651,
            "start_logit": -1.6922130584716797,
            "end_logit": -4.308062553405762,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Trans",
            "probability": 0.040225006418439464,
            "start_logit": -1.6922130584716797,
            "end_logit": -4.522754669189453,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved",
            "probability": 0.037937187020077784,
            "start_logit": -1.6922130584716797,
            "end_logit": -4.5813117027282715,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565 regions",
            "probability": 0.03293362882239795,
            "start_logit": -2.3163652420043945,
            "end_logit": -4.098597049713135,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "Transcribed ultraconserved regions (T-UCRs)",
            "probability": 0.03186602990787711,
            "start_logit": -1.6922130584716797,
            "end_logit": -4.755702972412109,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.022909241476871747,
            "start_logit": -4.988216876983643,
            "end_logit": -1.7896993160247803,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "regions",
            "probability": 0.018039054699023928,
            "start_logit": -5.227218151092529,
            "end_logit": -1.7896993160247803,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565 regions of lncRNAs and T-UCRs that are expressed in breast or breast cancer tissue,",
            "probability": 0.016535544540645087,
            "start_logit": -2.3163652420043945,
            "end_logit": -4.78757905960083,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "565 regions of lncRNAs",
            "probability": 0.013292437262752563,
            "start_logit": -2.3163652420043945,
            "end_logit": -5.005896091461182,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "56",
            "probability": 0.013013452400869773,
            "start_logit": -2.3163652420043945,
            "end_logit": -5.0271077156066895,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "selected 565",
            "probability": 0.010702833516330397,
            "start_logit": -4.014207363128662,
            "end_logit": -3.524740695953369,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565",
            "probability": 0.009016454901440565,
            "start_logit": -4.185664653778076,
            "end_logit": -3.524740695953369,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "selected 565 regions",
            "probability": 0.006029428120948302,
            "start_logit": -4.014207363128662,
            "end_logit": -4.098597049713135,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "single nucleotide polymorphisms",
            "probability": 0.00590493050397709,
            "start_logit": -4.131073474884033,
            "end_logit": -4.0025954246521,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565 regions",
            "probability": 0.005079408798712894,
            "start_logit": -4.185664653778076,
            "end_logit": -4.098597049713135,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "5",
            "probability": 0.003966402222584954,
            "start_logit": -5.006856441497803,
            "end_logit": -3.524740695953369,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "selected 565 regions of lncRNAs and T-UCRs that are expressed in breast or breast cancer tissue,",
            "probability": 0.003027297046013751,
            "start_logit": -4.014207363128662,
            "end_logit": -4.78757905960083,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        },
        {
            "text": "We selected 565 regions of lncRNAs and T-UCRs that are expressed in breast or breast cancer tissue,",
            "probability": 0.002550304762472455,
            "start_logit": -4.185664653778076,
            "end_logit": -4.78757905960083,
            "question_text": "List T-UCRs that have been implicated in breast cancer"
        }
    ],
    "5e36ad01b5b409ea53000006": [
        {
            "text": "transcribed ultraconserved regions",
            "probability": 0.5838003298935632,
            "start_logit": 0.35079336166381836,
            "end_logit": -0.3641977608203888,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+",
            "probability": 0.10560786546848265,
            "start_logit": 0.4889250099658966,
            "end_logit": -2.21215558052063,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63",
            "probability": 0.0997898503149812,
            "start_logit": 0.4889250099658966,
            "end_logit": -2.268821954727173,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "The transcribed ultraconserved regions",
            "probability": 0.04146475189298169,
            "start_logit": -2.293921947479248,
            "end_logit": -0.3641977608203888,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "ultraconserved regions",
            "probability": 0.03881779506354684,
            "start_logit": -2.359886884689331,
            "end_logit": -0.3641977608203888,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs)",
            "probability": 0.020711137524162065,
            "start_logit": 0.35079336166381836,
            "end_logit": -3.70308518409729,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) are a novel class of long non-coding RNAs",
            "probability": 0.017124793056133434,
            "start_logit": 0.35079336166381836,
            "end_logit": -3.8932294845581055,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) are a novel class",
            "probability": 0.01163882418395,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.279410362243652,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+, there are no reports mentioning its importance in gastric cancer (GC) biology.",
            "probability": 0.009831691038821942,
            "start_logit": 0.4889250099658966,
            "end_logit": -4.586277484893799,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved",
            "probability": 0.009706978244661577,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.460911750793457,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+, there are no reports mentioning its importance in gastric cancer",
            "probability": 0.009370681413540641,
            "start_logit": 0.4889250099658966,
            "end_logit": -4.634302616119385,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "trans",
            "probability": 0.009141361435781198,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.520947456359863,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) are a novel",
            "probability": 0.00831709138839541,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.615444183349609,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultraconserved regions (T-UCRs) are a novel class of long non-coding RNAs and are involved",
            "probability": 0.00817540495071138,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.632626533508301,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "Uc.63+,",
            "probability": 0.008082655916768752,
            "start_logit": 0.4889250099658966,
            "end_logit": -4.782167911529541,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "transcribed ultra",
            "probability": 0.006702373858557168,
            "start_logit": 0.35079336166381836,
            "end_logit": -4.831295013427734,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "63+",
            "probability": 0.0034807895272838123,
            "start_logit": -2.923548698425293,
            "end_logit": -2.21215558052063,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "regions",
            "probability": 0.0034755741884866,
            "start_logit": -4.773005962371826,
            "end_logit": -0.3641977608203888,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "63",
            "probability": 0.00328903026649343,
            "start_logit": -2.923548698425293,
            "end_logit": -2.268821954727173,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        },
        {
            "text": "The transcribed ultraconserved regions (T-UCRs)",
            "probability": 0.0014710203726972433,
            "start_logit": -2.293921947479248,
            "end_logit": -3.70308518409729,
            "question_text": "Which T-UCRs have been implicated in gastric cancer?"
        }
    ],
    "5e46e8c13f5415952900000c": [
        {
            "text": "pyrimidine dimers",
            "probability": 0.956029398423195,
            "start_logit": 3.921971559524536,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dimers",
            "probability": 0.028824605405818302,
            "start_logit": 0.4204122722148895,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions",
            "probability": 0.007779186650637906,
            "start_logit": 1.3163529634475708,
            "end_logit": 1.2543728351593018,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried",
            "probability": 0.0018668624556425618,
            "start_logit": 1.3163529634475708,
            "end_logit": -0.17281976342201233,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "p",
            "probability": 0.0012179667628376704,
            "start_logit": 3.921971559524536,
            "end_logit": -3.205514669418335,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine",
            "probability": 0.0009467396506134632,
            "start_logit": 3.921971559524536,
            "end_logit": -3.4574286937713623,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimers throughout the genome",
            "probability": 0.0005957128265079643,
            "start_logit": 3.921971559524536,
            "end_logit": -3.92069411277771,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dim",
            "probability": 0.00045605191204024445,
            "start_logit": 3.921971559524536,
            "end_logit": -4.1878461837768555,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions that face the histone core",
            "probability": 0.00034252233294478274,
            "start_logit": 1.3163529634475708,
            "end_logit": -1.868497371673584,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "ers",
            "probability": 0.00033908042835815045,
            "start_logit": -4.022335052490234,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "induced pyrimidine dimers",
            "probability": 0.00031853066008602005,
            "start_logit": -4.084853649139404,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "DNA-binding protein (UV-DDB) complex detects UV-light-induced pyrimidine dimers",
            "probability": 0.0002458487539905669,
            "start_logit": -4.343855857849121,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "lesions",
            "probability": 0.00024082003851627387,
            "start_logit": -2.158804178237915,
            "end_logit": 1.2543728351593018,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "pyrimidine dimers throughout the genome;",
            "probability": 0.0002357019714182152,
            "start_logit": 3.921971559524536,
            "end_logit": -4.847884654998779,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "ine dimers",
            "probability": 0.00022338325892906508,
            "start_logit": -4.439683437347412,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "buried lesions that face the histone core,",
            "probability": 0.00018080298739543487,
            "start_logit": 1.3163529634475708,
            "end_logit": -2.5074262619018555,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "yrimidine dimers",
            "probability": 0.00010016327847568726,
            "start_logit": -5.2417707443237305,
            "end_logit": 3.4600911140441895,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "In the case of buried lesions",
            "probability": 2.3963427683435705e-05,
            "start_logit": -4.466325283050537,
            "end_logit": 1.2543728351593018,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "dimers throughout the genome",
            "probability": 1.7960940518772402e-05,
            "start_logit": 0.4204122722148895,
            "end_logit": -3.92069411277771,
            "question_text": "List types of DNA lesions caused by UV light."
        },
        {
            "text": "lesions located in the solvent-facing minor groove without affecting the overall nucleosome architecture. In the case of buried lesions",
            "probability": 1.4697834390118032e-05,
            "start_logit": -4.955153942108154,
            "end_logit": 1.2543728351593018,
            "question_text": "List types of DNA lesions caused by UV light."
        }
    ],
    "5cd96eb2a49efeb44c000003": [
        {
            "text": "CNN-IndRNN",
            "probability": 0.2636382994787673,
            "start_logit": -0.7492802143096924,
            "end_logit": -2.3217310905456543,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN",
            "probability": 0.12711454896783275,
            "start_logit": -1.4787696599960327,
            "end_logit": -2.3217310905456543,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net",
            "probability": 0.10851679421862369,
            "start_logit": -0.7492802143096924,
            "end_logit": -3.209404230117798,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net",
            "probability": 0.06715038191657373,
            "start_logit": -1.2292505502700806,
            "end_logit": -3.209404230117798,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN classification model is constructed by improving the Independently Recurrent Neural Net",
            "probability": 0.05232192507616446,
            "start_logit": -1.4787696599960327,
            "end_logit": -3.209404230117798,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN)",
            "probability": 0.05065525147007275,
            "start_logit": -0.7492802143096924,
            "end_logit": -3.971266269683838,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN) algorithm",
            "probability": 0.03486272145679294,
            "start_logit": -0.7492802143096924,
            "end_logit": -4.34489107131958,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net",
            "probability": 0.0344665453305126,
            "start_logit": -1.8961960077285767,
            "end_logit": -3.209404230117798,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net-work (IndRNN)",
            "probability": 0.031345558139531715,
            "start_logit": -1.2292505502700806,
            "end_logit": -3.971266269683838,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN)",
            "probability": 0.026466922716386673,
            "start_logit": -1.3984273672103882,
            "end_logit": -3.971266269683838,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN",
            "probability": 0.025619178898222673,
            "start_logit": -0.7492802143096924,
            "end_logit": -4.652967929840088,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Recurrent Neural",
            "probability": 0.025521635653792688,
            "start_logit": -0.7492802143096924,
            "end_logit": -4.656782627105713,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN)",
            "probability": 0.024423687515057066,
            "start_logit": -1.4787696599960327,
            "end_logit": -3.971266269683838,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Recurrent Neural Net-work (IndRNN) algorithm",
            "probability": 0.021573112966813066,
            "start_logit": -1.2292505502700806,
            "end_logit": -4.34489107131958,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification",
            "probability": 0.01998680219717833,
            "start_logit": -0.7492802143096924,
            "end_logit": -4.9012370109558105,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "C",
            "probability": 0.01835857784876865,
            "start_logit": -0.7492802143096924,
            "end_logit": -4.986212253570557,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN) algorithm",
            "probability": 0.018215464886695766,
            "start_logit": -1.3984273672103882,
            "end_logit": -4.34489107131958,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "CNN-IndRNN classification model is constructed by improving the Independently Re",
            "probability": 0.016864492431141978,
            "start_logit": -0.7492802143096924,
            "end_logit": -5.071098804473877,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "IndRNN classification model is constructed by improving the Independently Recurrent Neural Net-work (IndRNN) algorithm",
            "probability": 0.016809238727957757,
            "start_logit": -1.4787696599960327,
            "end_logit": -4.34489107131958,
            "question_text": "Which software are used for the detection of selective sweeps?"
        },
        {
            "text": "Neural Net-work (IndRNN)",
            "probability": 0.01608886010311336,
            "start_logit": -1.8961960077285767,
            "end_logit": -3.971266269683838,
            "question_text": "Which software are used for the detection of selective sweeps?"
        }
    ],
    "5c70273c7c78d69471000061": [
        {
            "text": "systemic lupus erythematosus",
            "probability": 0.5508657859961865,
            "start_logit": -1.8588470220565796,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus",
            "probability": 0.10779154373550864,
            "start_logit": -1.8588470220565796,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus erythematosus",
            "probability": 0.08411197934620215,
            "start_logit": -3.738189220428467,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "At least half of patients with systemic lupus erythematosus",
            "probability": 0.056122748289760216,
            "start_logit": -4.142796993255615,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease",
            "probability": 0.03155255282425295,
            "start_logit": -1.8588470220565796,
            "end_logit": -4.386176586151123,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage",
            "probability": 0.029748889785538735,
            "start_logit": -1.8588470220565796,
            "end_logit": -4.44503927230835,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "half of patients with systemic lupus erythematosus",
            "probability": 0.02083081300560102,
            "start_logit": -5.133904933929443,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus",
            "probability": 0.016458746088178936,
            "start_logit": -3.738189220428467,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "sus",
            "probability": 0.014226475525511333,
            "start_logit": -5.515233516693115,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "erythematosus",
            "probability": 0.013948656483951176,
            "start_logit": -5.534955024719238,
            "end_logit": -1.5263398885726929,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune",
            "probability": 0.013499145522549404,
            "start_logit": -1.8588470220565796,
            "end_logit": -5.235204696655273,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "At least half of patients with systemic lupus",
            "probability": 0.010981908534930342,
            "start_logit": -4.142796993255615,
            "end_logit": -3.1576318740844727,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "systemic",
            "probability": 0.01083225622314821,
            "start_logit": -1.8588470220565796,
            "end_logit": -5.455302715301514,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "This study synthesised evidence on the association between organ damage and mortality",
            "probability": 0.006578187201471161,
            "start_logit": -3.9087471961975098,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "autoimmune disease or long-term therapeutic steroid use. This study synthesised evidence on the association between organ damage and mortality",
            "probability": 0.0060919306951170244,
            "start_logit": -3.985541343688965,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "This study synthesised evidence on the association between organ damage and mortality in patients with SLE.",
            "probability": 0.0060239182982749,
            "start_logit": -3.9087471961975098,
            "end_logit": -3.9921929836273193,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "mortality",
            "probability": 0.005423675224821077,
            "start_logit": -4.1017327308654785,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "synthesised evidence on the association between organ damage and mortality",
            "probability": 0.005126327853373403,
            "start_logit": -4.158116817474365,
            "end_logit": -3.9041717052459717,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "mortality in patients with SLE.",
            "probability": 0.004966683894826393,
            "start_logit": -4.1017327308654785,
            "end_logit": -3.9921929836273193,
            "question_text": "Which organs are primarily damaged in SLE?"
        },
        {
            "text": "lupus erythematosus (SLE) develop organ damage as a consequence of autoimmune disease",
            "probability": 0.0048177754707966,
            "start_logit": -3.738189220428467,
            "end_logit": -4.386176586151123,
            "question_text": "Which organs are primarily damaged in SLE?"
        }
    ],
    "5c7a4ed5d774d04240000008": [
        {
            "text": "minimally invasive",
            "probability": 0.5488174103045093,
            "start_logit": 4.829140663146973,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive",
            "probability": 0.1042662724001341,
            "start_logit": 4.621838569641113,
            "end_logit": 3.51008677482605,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive",
            "probability": 0.08012259301600634,
            "start_logit": 4.358448505401611,
            "end_logit": 3.51008677482605,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "diagnostic",
            "probability": 0.07373382201403637,
            "start_logit": 4.851922035217285,
            "end_logit": 2.9335169792175293,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive, and diagnostic",
            "probability": 0.05857910968795877,
            "start_logit": 4.621838569641113,
            "end_logit": 2.9335169792175293,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic",
            "probability": 0.050740626229996456,
            "start_logit": 4.358448505401611,
            "end_logit": 3.053255796432495,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive, and diagnostic",
            "probability": 0.045014653892645334,
            "start_logit": 4.358448505401611,
            "end_logit": 2.9335169792175293,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "analysis of circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blood. Because the technique is minimally invasive",
            "probability": 0.008459374235547445,
            "start_logit": 0.6566500663757324,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "diagnostic method",
            "probability": 0.0056707358434033,
            "start_logit": 4.851922035217285,
            "end_logit": 0.3683742582798004,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "predictive, and diagnostic method",
            "probability": 0.004505214132517428,
            "start_logit": 4.621838569641113,
            "end_logit": 0.3683742582798004,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "prognostic, predictive, and diagnostic method",
            "probability": 0.003461996195705464,
            "start_logit": 4.358448505401611,
            "end_logit": 0.3683742582798004,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "minimally invasive, liquid biopsies are the future in cancer management. Epidermal growth factor receptor",
            "probability": 0.0033046981965015746,
            "start_logit": 4.829140663146973,
            "end_logit": -0.14881810545921326,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "minimally invasive, liquid biopsies are the future in cancer management",
            "probability": 0.0027981148187077027,
            "start_logit": 4.829140663146973,
            "end_logit": -0.31521734595298767,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "technique is minimally invasive",
            "probability": 0.0026605937707484275,
            "start_logit": -0.5000758171081543,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "minimally invasive,",
            "probability": 0.0020517591892543537,
            "start_logit": 4.829140663146973,
            "end_logit": -0.6254656910896301,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "Because the technique is minimally invasive",
            "probability": 0.0018104661925114028,
            "start_logit": -0.8850407600402832,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "circulating cell-free tumor DNA (ctDNA) in various body fluids, primarily blood. Because the technique is minimally invasive",
            "probability": 0.0012811267818658642,
            "start_logit": -1.2308851480484009,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "tyrosine kinase inhibitor treatment. In the near future, liquid biopsy will be a crucial prognostic, predictive",
            "probability": 0.0012246301169556999,
            "start_logit": 0.1775294840335846,
            "end_logit": 3.51008677482605,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "tyrosine kinase inhibitor treatment. In the near future, liquid biopsy will be a crucial prognostic",
            "probability": 0.0007755427863153707,
            "start_logit": 0.1775294840335846,
            "end_logit": 3.053255796432495,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        },
        {
            "text": "invasive",
            "probability": 0.0007212601946789585,
            "start_logit": -1.8053804636001587,
            "end_logit": 4.963602542877197,
            "question_text": "What are the advantages of liquid biopsy in NSCLC?"
        }
    ],
    "5c7006037c78d6947100005d": [
        {
            "text": "amyloid A",
            "probability": 0.3538877657311716,
            "start_logit": 1.6973603963851929,
            "end_logit": 1.3930728435516357,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate",
            "probability": 0.30571298934624247,
            "start_logit": 1.701274037361145,
            "end_logit": 1.2428261041641235,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum amyloid A",
            "probability": 0.20457222030457117,
            "start_logit": 1.1493016481399536,
            "end_logit": 1.3930728435516357,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR), and hypersensitive C-reactive protein",
            "probability": 0.0582426588565955,
            "start_logit": 1.701274037361145,
            "end_logit": -0.4152025580406189,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "hypersensitive C-reactive protein",
            "probability": 0.04269380282229157,
            "start_logit": 1.3907097578048706,
            "end_logit": -0.4152025580406189,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "sedimentation rate",
            "probability": 0.007645547298938813,
            "start_logit": -1.9872492551803589,
            "end_logit": 1.2428261041641235,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "C-reactive protein",
            "probability": 0.005768501058127812,
            "start_logit": -0.6109317541122437,
            "end_logit": -0.4152025580406189,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR), and hypersensitive C-reactive protein (Hs-CRP)",
            "probability": 0.002950183413436898,
            "start_logit": 1.701274037361145,
            "end_logit": -3.3979532718658447,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR)",
            "probability": 0.00275966798922893,
            "start_logit": 1.701274037361145,
            "end_logit": -3.464710235595703,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "amyloid A (SAA",
            "probability": 0.0025312885123286877,
            "start_logit": 1.6973603963851929,
            "end_logit": -3.5471785068511963,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "SLE Disease Activity Index 2000",
            "probability": 0.0024387847994045697,
            "start_logit": -0.669405460357666,
            "end_logit": -1.2176412343978882,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "hypersensitive C-reactive protein (Hs-CRP)",
            "probability": 0.0021625823994916526,
            "start_logit": 1.3907097578048706,
            "end_logit": -3.3979532718658447,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum amyloid A (SAA",
            "probability": 0.0014632642361304504,
            "start_logit": 1.1493016481399536,
            "end_logit": -3.5471785068511963,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "sedimentation rate (ESR), and hypersensitive C-reactive protein",
            "probability": 0.0014565851587016695,
            "start_logit": -1.9872492551803589,
            "end_logit": -0.4152025580406189,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "the erythrocyte sedimentation rate",
            "probability": 0.0014143051170467183,
            "start_logit": -3.674734354019165,
            "end_logit": 1.2428261041641235,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "er",
            "probability": 0.0010489822979594628,
            "start_logit": 1.701274037361145,
            "end_logit": -4.432000160217285,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "erythrocyte sedimentation rate (ESR), and hypersensitive",
            "probability": 0.0009926470435659132,
            "start_logit": 1.701274037361145,
            "end_logit": -4.487200736999512,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "A",
            "probability": 0.0007685527684235442,
            "start_logit": -4.434865474700928,
            "end_logit": 1.3930728435516357,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "serum",
            "probability": 0.0007620276037070297,
            "start_logit": 1.1493016481399536,
            "end_logit": -4.199620723724365,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        },
        {
            "text": "hypersensitive",
            "probability": 0.000727643242635627,
            "start_logit": 1.3907097578048706,
            "end_logit": -4.487200736999512,
            "question_text": "Which characteristics are used in the SLEDAI index for SLE patients?"
        }
    ],
    "5c74305d7c78d694710000a4": [
        {
            "text": "RIN/G3BPs",
            "probability": 0.5181896325739459,
            "start_logit": 3.5594067573547363,
            "end_logit": 3.206188917160034,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs",
            "probability": 0.327790894174791,
            "start_logit": 3.1014413833618164,
            "end_logit": 3.206188917160034,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN",
            "probability": 0.14329151861106387,
            "start_logit": 3.5594067573547363,
            "end_logit": 1.9207288026809692,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs",
            "probability": 0.0035062633541727275,
            "start_logit": 3.5594067573547363,
            "end_logit": -1.789601445198059,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs",
            "probability": 0.0022179548331904765,
            "start_logit": 3.1014413833618164,
            "end_logit": -1.789601445198059,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs",
            "probability": 0.0007403987766768092,
            "start_logit": 3.5594067573547363,
            "end_logit": -3.3447186946868896,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target mRNAs.",
            "probability": 0.0006345302116371554,
            "start_logit": 3.5594067573547363,
            "end_logit": -3.4990227222442627,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away from their short target",
            "probability": 0.0005552781736081274,
            "start_logit": 3.5594067573547363,
            "end_logit": -3.6324384212493896,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs",
            "probability": 0.0004683535945080489,
            "start_logit": 3.1014413833618164,
            "end_logit": -3.3447186946868896,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "incorporation of RIN/G3BPs",
            "probability": 0.0004660886208253122,
            "start_logit": -3.4543139934539795,
            "end_logit": 3.206188917160034,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target mRNAs.",
            "probability": 0.00040138438204624215,
            "start_logit": 3.1014413833618164,
            "end_logit": -3.4990227222442627,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away from their short target",
            "probability": 0.0003512519695514736,
            "start_logit": 3.1014413833618164,
            "end_logit": -3.6324384212493896,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G",
            "probability": 0.0003138199267132429,
            "start_logit": 3.5594067573547363,
            "end_logit": -4.203088283538818,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "R",
            "probability": 0.00023472688557378915,
            "start_logit": 3.5594067573547363,
            "end_logit": -4.493484973907471,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G",
            "probability": 0.00019851287621529569,
            "start_logit": 3.1014413833618164,
            "end_logit": -4.203088283538818,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "RIN/G3BPs into SGs sequesters them away",
            "probability": 0.00019383861588382126,
            "start_logit": 3.5594067573547363,
            "end_logit": -4.684881687164307,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "incorporation of RIN",
            "probability": 0.0001288843737642027,
            "start_logit": -3.4543139934539795,
            "end_logit": 1.9207288026809692,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "G3BPs into SGs sequesters them away",
            "probability": 0.000122616372910731,
            "start_logit": 3.1014413833618164,
            "end_logit": -4.684881687164307,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "Ps",
            "probability": 0.00011210606761263722,
            "start_logit": -4.879244327545166,
            "end_logit": 3.206188917160034,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        },
        {
            "text": "when cells are stressed, the resulting incorporation of RIN/G3BPs",
            "probability": 8.194560530910877e-05,
            "start_logit": -5.192634105682373,
            "end_logit": 3.206188917160034,
            "question_text": "Which mRNAs are sequestered in stress granules?"
        }
    ],
    "5c7a4a31d774d04240000006": [
        {
            "text": "limitations in sensitivity and reproducibility",
            "probability": 0.19002954710274197,
            "start_logit": 1.8603945970535278,
            "end_logit": 1.6197829246520996,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "limitations",
            "probability": 0.17975094470694092,
            "start_logit": 1.8603945970535278,
            "end_logit": 1.5641756057739258,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "limitations in sensitivity",
            "probability": 0.15401457036203028,
            "start_logit": 1.8603945970535278,
            "end_logit": 1.4096505641937256,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "limitations in sensitivity and reproducibility for clinical use",
            "probability": 0.10260808980148299,
            "start_logit": 1.8603945970535278,
            "end_logit": 1.003520131111145,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "enzyme-linked immunosorbent assays to measure these soluble factors have limitations in sensitivity and reproducibility",
            "probability": 0.058042484308660255,
            "start_logit": 0.6743902564048767,
            "end_logit": 1.6197829246520996,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "enzyme-linked immunosorbent assays to measure these soluble factors have limitations",
            "probability": 0.05490299559561984,
            "start_logit": 0.6743902564048767,
            "end_logit": 1.5641756057739258,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "enzyme-linked immunosorbent assays to measure these soluble factors have limitations in sensitivity",
            "probability": 0.04704209645203225,
            "start_logit": 0.6743902564048767,
            "end_logit": 1.4096505641937256,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "enzyme-linked immunosorbent assays to measure these soluble factors have limitations in sensitivity and reproducibility for clinical use",
            "probability": 0.03134053905324623,
            "start_logit": 0.6743902564048767,
            "end_logit": 1.003520131111145,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "available methods such as enzyme-linked immunosorbent assays to measure these soluble factors have limitations in sensitivity and reproducibility",
            "probability": 0.02967560002860639,
            "start_logit": 0.0035401862114667892,
            "end_logit": 1.6197829246520996,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "available methods such as enzyme-linked immunosorbent assays to measure these soluble factors have limitations",
            "probability": 0.028070461784573467,
            "start_logit": 0.0035401862114667892,
            "end_logit": 1.5641756057739258,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "available methods such as enzyme-linked immunosorbent assays to measure these soluble factors have limitations in sensitivity",
            "probability": 0.02405139020917721,
            "start_logit": 0.0035401862114667892,
            "end_logit": 1.4096505641937256,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "sensitivity and reproducibility",
            "probability": 0.02060152470232998,
            "start_logit": -0.3614198863506317,
            "end_logit": 1.6197829246520996,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "reproducibility",
            "probability": 0.017782189656422923,
            "start_logit": -0.5085875988006592,
            "end_logit": 1.6197829246520996,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "sensitivity",
            "probability": 0.01669706118973497,
            "start_logit": -0.3614198863506317,
            "end_logit": 1.4096505641937256,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "sensitivity and reproducibility for clinical use",
            "probability": 0.011123970608429888,
            "start_logit": -0.3614198863506317,
            "end_logit": 1.003520131111145,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "enzyme-linked immunosorbent assays",
            "probability": 0.010097032386796906,
            "start_logit": 0.6743902564048767,
            "end_logit": -0.12915074825286865,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "reproducibility for clinical use",
            "probability": 0.009601646380532357,
            "start_logit": -0.5085875988006592,
            "end_logit": 1.003520131111145,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "limitations in sensitivity and reproducibility for clinical use. To overcome these problems",
            "probability": 0.007048483562506118,
            "start_logit": 1.8603945970535278,
            "end_logit": -1.674584150314331,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "available methods such as enzyme-linked immunosorbent assays",
            "probability": 0.005162347858734963,
            "start_logit": 0.0035401862114667892,
            "end_logit": -0.12915074825286865,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        },
        {
            "text": "available methods",
            "probability": 0.002357024249399989,
            "start_logit": 0.0035401862114667892,
            "end_logit": -0.9131423234939575,
            "question_text": "Which are the problems associated with the use of PD-L1 as immunotherapy biomarker?"
        }
    ],
    "5e360f3d158f994d3a000009": [
        {
            "text": "constipation",
            "probability": 0.503382763231191,
            "start_logit": 4.148484706878662,
            "end_logit": 3.9415395259857178,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic constipation",
            "probability": 0.417256489124344,
            "start_logit": 3.9608349800109863,
            "end_logit": 3.9415395259857178,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss",
            "probability": 0.05749710616850343,
            "start_logit": 3.4392919540405273,
            "end_logit": 2.4811160564422607,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary abnormalities",
            "probability": 0.014065625476923747,
            "start_logit": 3.4392919540405273,
            "end_logit": 1.073115348815918,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing",
            "probability": 0.0022749122669495267,
            "start_logit": 3.4392919540405273,
            "end_logit": -0.7486770749092102,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "persistent chronic constipation",
            "probability": 0.0015812405325746769,
            "start_logit": -1.6146564483642578,
            "end_logit": 3.9415395259857178,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "pigmentary abnormalities",
            "probability": 0.0012252950556589292,
            "start_logit": 0.9987397193908691,
            "end_logit": 1.073115348815918,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic",
            "probability": 0.0005576748477005118,
            "start_logit": 3.9608349800109863,
            "end_logit": -2.676140785217285,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "con",
            "probability": 0.0004623236167719094,
            "start_logit": 4.148484706878662,
            "end_logit": -3.0513014793395996,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "ation",
            "probability": 0.0003868184401472404,
            "start_logit": -3.0226659774780273,
            "end_logit": 3.9415395259857178,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic con",
            "probability": 0.00038322235734742076,
            "start_logit": 3.9608349800109863,
            "end_logit": -3.0513014793395996,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "constipation since the neonatal period,",
            "probability": 0.00027404825768291124,
            "start_logit": 4.148484706878662,
            "end_logit": -3.5742623805999756,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic constipation since the neonatal period,",
            "probability": 0.00022715997090845509,
            "start_logit": 3.9608349800109863,
            "end_logit": -3.5742623805999756,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "loss",
            "probability": 0.00012027229305579686,
            "start_logit": -2.7304396629333496,
            "end_logit": 2.4811160564422607,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "constipation since the neonatal period",
            "probability": 6.486571756763977e-05,
            "start_logit": 4.148484706878662,
            "end_logit": -5.015247344970703,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary",
            "probability": 5.507760128963353e-05,
            "start_logit": 3.4392919540405273,
            "end_logit": -4.469630718231201,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "constipation since the neonatal period, symptoms suggestive of Waardenburg syndrome type 4",
            "probability": 5.4108946174328005e-05,
            "start_logit": 4.148484706878662,
            "end_logit": -5.196567058563232,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic constipation since the neonatal period",
            "probability": 5.376751759053396e-05,
            "start_logit": 3.9608349800109863,
            "end_logit": -5.015247344970703,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "chronic constipation since the neonatal period, symptoms suggestive of Waardenburg syndrome type 4",
            "probability": 4.485117600371434e-05,
            "start_logit": 3.9608349800109863,
            "end_logit": -5.196567058563232,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        },
        {
            "text": "hearing loss and pigmentary abnormalities with variable penetrance",
            "probability": 3.237740161460324e-05,
            "start_logit": 3.4392919540405273,
            "end_logit": -5.000913143157959,
            "question_text": "What are 3 symptoms of Waardenburg Syndrome?"
        }
    ],
    "5e493bc06d0a277941000003": [
        {
            "text": "lung cancer",
            "probability": 0.8970876039056357,
            "start_logit": 3.4633307456970215,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung",
            "probability": 0.0800686933731586,
            "start_logit": 3.4633307456970215,
            "end_logit": 0.8352408409118652,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.012510643367508177,
            "start_logit": -0.8092430233955383,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancer",
            "probability": 0.0022257036236321384,
            "start_logit": -2.535749673843384,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers. Here, we investigated the effects of LINC-PINT on lung",
            "probability": 0.0011166254703919886,
            "start_logit": -0.8092430233955383,
            "end_logit": 0.8352408409118652,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0010364000358209057,
            "start_logit": -3.300069570541382,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer. All these findings concluded that LINC-PINT exerted crucial biological roles in NSCLC",
            "probability": 0.0008705413906562496,
            "start_logit": 2.1117770671844482,
            "end_logit": -2.334730386734009,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer progression.",
            "probability": 0.0007103273357185173,
            "start_logit": 3.4633307456970215,
            "end_logit": -3.8896734714508057,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0006814402972092664,
            "start_logit": -3.719369411468506,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "reported to participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0005422654932272681,
            "start_logit": -3.947822332382202,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "to participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.00048568456472513054,
            "start_logit": -4.058018684387207,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "has been reported to participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.00045723719184005327,
            "start_logit": -4.118375778198242,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "been reported to participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0004315952769264017,
            "start_logit": -4.176089763641357,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.0004228236568652476,
            "start_logit": -4.196622848510742,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer,",
            "probability": 0.00037096744436572037,
            "start_logit": 1.9010599851608276,
            "end_logit": -2.9770143032073975,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "s. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.00031921609383573187,
            "start_logit": -4.477709770202637,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "various cancers",
            "probability": 0.00026078070707399555,
            "start_logit": -0.8092430233955383,
            "end_logit": -0.6191457509994507,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": ") has been reported to participate in various cancers. Here, we investigated the effects of LINC-PINT on lung cancer",
            "probability": 0.00018448119115524998,
            "start_logit": -5.026030540466309,
            "end_logit": 3.251509428024292,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "lung cancer.",
            "probability": 0.0001244666894336588,
            "start_logit": 2.1117770671844482,
            "end_logit": -4.2798075675964355,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        },
        {
            "text": "cancers. Here, we investigated the effects of LINC-PINT on lung",
            "probability": 9.250289082001814e-05,
            "start_logit": -3.300069570541382,
            "end_logit": 0.8352408409118652,
            "question_text": "List types of cancer where Long intergenic nonprotein coding RNA p53-induced transcript (LINC-PINT) is involved"
        }
    ],
    "5e2f43bafbd6abf43b000029": [
        {
            "text": "severe acute respiratory syndrome",
            "probability": 0.27168812429586736,
            "start_logit": 4.251971244812012,
            "end_logit": 3.9334654808044434,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "COVID-19",
            "probability": 0.24433877339005997,
            "start_logit": 4.057683944702148,
            "end_logit": 4.021653652191162,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019 (COVID-19",
            "probability": 0.08965817292053274,
            "start_logit": 3.0551326274871826,
            "end_logit": 4.021653652191162,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease-2019",
            "probability": 0.06374150734382637,
            "start_logit": 4.251971244812012,
            "end_logit": 2.4836466312408447,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "SARS-CoV-2) in December 2019 which causes coronavirus disease-2019 (COVID-19",
            "probability": 0.06318133883630206,
            "start_logit": 2.705137252807617,
            "end_logit": 4.021653652191162,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2",
            "probability": 0.0543469646543926,
            "start_logit": 4.251971244812012,
            "end_logit": 2.3241994380950928,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "COVID-19)",
            "probability": 0.03831665014968503,
            "start_logit": 4.057683944702148,
            "end_logit": 2.16898250579834,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2",
            "probability": 0.023773850822950755,
            "start_logit": 4.251971244812012,
            "end_logit": 1.4973969459533691,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019",
            "probability": 0.019259363146529613,
            "start_logit": 3.0551326274871826,
            "end_logit": 2.4836466312408447,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "acute respiratory syndrome",
            "probability": 0.016302699584380177,
            "start_logit": 1.4386471509933472,
            "end_logit": 3.9334654808044434,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "(COVID-19",
            "probability": 0.01567966691918346,
            "start_logit": 1.3114930391311646,
            "end_logit": 4.021653652191162,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "coronavirus disease-2019 (COVID-19)",
            "probability": 0.0140599905499721,
            "start_logit": 3.0551326274871826,
            "end_logit": 2.16898250579834,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "SARS-CoV-2) in December 2019 which causes coronavirus disease-2019",
            "probability": 0.013571906599198696,
            "start_logit": 2.705137252807617,
            "end_logit": 2.4836466312408447,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)",
            "probability": 0.013310148681349701,
            "start_logit": 4.251971244812012,
            "end_logit": 0.9173374772071838,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus",
            "probability": 0.011886814860858175,
            "start_logit": 4.251971244812012,
            "end_logit": 0.8042404651641846,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "SARS-CoV-2",
            "probability": 0.011571611011028406,
            "start_logit": 2.705137252807617,
            "end_logit": 2.3241994380950928,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "SARS-CoV-2) in December 2019 which causes coronavirus disease-2019 (COVID-19)",
            "probability": 0.009907953709477777,
            "start_logit": 2.705137252807617,
            "end_logit": 2.16898250579834,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "COVID-19),",
            "probability": 0.009865363962224146,
            "start_logit": 4.057683944702148,
            "end_logit": 0.8121280074119568,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in December 2019 which causes coronavirus disease",
            "probability": 0.009435252224832134,
            "start_logit": 4.251971244812012,
            "end_logit": 0.5732635855674744,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        },
        {
            "text": "CoV-2) in December 2019 which causes coronavirus disease-2019 (COVID-19",
            "probability": 0.006103846337348715,
            "start_logit": 0.3680473864078522,
            "end_logit": 4.021653652191162,
            "question_text": "Please list 2 human diseases caused by a coronavirus."
        }
    ],
    "5e5cbf4e1af46fc130000004": [
        {
            "text": "amino acids and their analogs",
            "probability": 0.2010468687126034,
            "start_logit": -3.0192432403564453,
            "end_logit": -4.2374773025512695,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation",
            "probability": 0.12362777792202656,
            "start_logit": -3.0192432403564453,
            "end_logit": -4.723740100860596,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids",
            "probability": 0.11930852021872525,
            "start_logit": -3.0192432403564453,
            "end_logit": -4.759302616119385,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation. These radioprotective agents",
            "probability": 0.10100429718948481,
            "start_logit": -3.0192432403564453,
            "end_logit": -4.925852298736572,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl compounds",
            "probability": 0.07078537069142236,
            "start_logit": -3.9455642700195312,
            "end_logit": -4.355041980743408,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl-containing compounds",
            "probability": 0.06372409103151506,
            "start_logit": -3.9110054969787598,
            "end_logit": -4.494690418243408,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "non-sulfhydryl-containing amino acids",
            "probability": 0.04253115909966279,
            "start_logit": -3.9554922580718994,
            "end_logit": -4.85452938079834,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids and their analogs are capable of protecting biological systems from the toxic effects of ionizing radiation.",
            "probability": 0.04159479771848327,
            "start_logit": -3.0192432403564453,
            "end_logit": -5.813040256500244,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino",
            "probability": 0.03506804406029021,
            "start_logit": -3.0192432403564453,
            "end_logit": -5.983725070953369,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "amino acids are also being investigated for their radioprotective effects. These agents are less well known than the familiar sulfhydryl compounds",
            "probability": 0.029022704711562135,
            "start_logit": -4.8371381759643555,
            "end_logit": -4.355041980743408,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "non-sulfhydryl-containing amino acids are also being investigated for their radioprotective effects.",
            "probability": 0.027024950546420463,
            "start_logit": -3.9554922580718994,
            "end_logit": -5.3080058097839355,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ionizing radiation",
            "probability": 0.01972643384589278,
            "start_logit": -4.854558944702148,
            "end_logit": -4.723740100860596,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl group. The sulfhydryl-containing compounds",
            "probability": 0.01918368715606643,
            "start_logit": -5.111507892608643,
            "end_logit": -4.494690418243408,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Several non-sulfhydryl-containing amino acids",
            "probability": 0.018800454008069234,
            "start_logit": -4.771848201751709,
            "end_logit": -4.85452938079834,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "ionizing radiation. These radioprotective agents",
            "probability": 0.016116560696544505,
            "start_logit": -4.854558944702148,
            "end_logit": -4.925852298736572,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "free radical scavenging and hydrogen atom donation. Several non-sulfhydryl-containing amino acids",
            "probability": 0.01566425137103532,
            "start_logit": -4.954348087310791,
            "end_logit": -4.85452938079834,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "non-sulfhydryl-containing amino acids are also being investigated for their radioprotective effects",
            "probability": 0.015298905200239176,
            "start_logit": -3.9554922580718994,
            "end_logit": -5.8769850730896,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl compounds, but possess very interesting protective qualities. In short, the study of amino acids",
            "probability": 0.01497405547005203,
            "start_logit": -3.9455642700195312,
            "end_logit": -5.908375263214111,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "sulfhydryl-containing compounds have been studied extensively and are thought to exert their radioprotective effects",
            "probability": 0.013550973639308071,
            "start_logit": -3.9110054969787598,
            "end_logit": -6.042794704437256,
            "question_text": "List approved radioprotective compounds"
        },
        {
            "text": "Several non-sulfhydryl-containing amino acids are also being investigated for their radioprotective effects.",
            "probability": 0.011946096710596155,
            "start_logit": -4.771848201751709,
            "end_logit": -5.3080058097839355,
            "question_text": "List approved radioprotective compounds"
        }
    ],
    "5e48100bd14c9f295d000007": [
        {
            "text": "thyroid",
            "probability": 0.0944407093251779,
            "start_logit": 4.751762866973877,
            "end_logit": 4.170145511627197,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon",
            "probability": 0.09089310144318394,
            "start_logit": 4.589933395385742,
            "end_logit": 4.293686866760254,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast",
            "probability": 0.08345772939208135,
            "start_logit": 4.589933395385742,
            "end_logit": 4.208343029022217,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid",
            "probability": 0.08032996797007251,
            "start_logit": 4.589933395385742,
            "end_logit": 4.170145511627197,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder cancer",
            "probability": 0.06866022772592682,
            "start_logit": 4.751762866973877,
            "end_logit": 3.8513433933258057,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder cancer",
            "probability": 0.05840144502780816,
            "start_logit": 4.589933395385742,
            "end_logit": 3.8513433933258057,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder",
            "probability": 0.05759479775816061,
            "start_logit": 4.751762866973877,
            "end_logit": 3.675605535507202,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder",
            "probability": 0.04898934254322037,
            "start_logit": 4.589933395385742,
            "end_logit": 3.675605535507202,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "bladder cancer",
            "probability": 0.045050898246573004,
            "start_logit": 4.330385684967041,
            "end_logit": 3.8513433933258057,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast",
            "probability": 0.04028183807987255,
            "start_logit": 3.8614938259124756,
            "end_logit": 4.208343029022217,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast, thyroid",
            "probability": 0.03877218786446918,
            "start_logit": 3.8614938259124756,
            "end_logit": 4.170145511627197,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon",
            "probability": 0.03826611004864658,
            "start_logit": 3.724813938140869,
            "end_logit": 4.293686866760254,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "bladder",
            "probability": 0.03779039859425137,
            "start_logit": 4.330385684967041,
            "end_logit": 3.675605535507202,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "thyroid, and bladder cancers",
            "probability": 0.03550566971529973,
            "start_logit": 4.751762866973877,
            "end_logit": 3.1918656826019287,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon, female breast",
            "probability": 0.03513580906163521,
            "start_logit": 3.724813938140869,
            "end_logit": 4.208343029022217,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon, female breast, thyroid",
            "probability": 0.033819017568330126,
            "start_logit": 3.724813938140869,
            "end_logit": 4.170145511627197,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "colon, female breast, thyroid, and bladder cancers",
            "probability": 0.03020063414777438,
            "start_logit": 4.589933395385742,
            "end_logit": 3.1918656826019287,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung",
            "probability": 0.029634900947839146,
            "start_logit": 3.724813938140869,
            "end_logit": 4.038074970245361,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "female breast, thyroid, and bladder cancer",
            "probability": 0.028188132715529623,
            "start_logit": 3.8614938259124756,
            "end_logit": 3.8513433933258057,
            "question_text": "List the most common cancers after a radiation exposure?"
        },
        {
            "text": "lung, colon, female breast, thyroid, and bladder cancer",
            "probability": 0.02458708182414737,
            "start_logit": 3.724813938140869,
            "end_logit": 3.8513433933258057,
            "question_text": "List the most common cancers after a radiation exposure?"
        }
    ],
    "5cf0f567a49efeb44c00000b": [
        {
            "text": "MBF",
            "probability": 0.11157882785946763,
            "start_logit": 5.614424228668213,
            "end_logit": 4.84125280380249,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF",
            "probability": 0.09740486124556333,
            "start_logit": 5.614424228668213,
            "end_logit": 4.705397605895996,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6) and SBF",
            "probability": 0.07486834339521568,
            "start_logit": 5.351279258728027,
            "end_logit": 4.705397605895996,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF",
            "probability": 0.06917394966859695,
            "start_logit": 5.272172451019287,
            "end_logit": 4.705397605895996,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF (Swi4",
            "probability": 0.06687904763342112,
            "start_logit": 5.614424228668213,
            "end_logit": 4.329407215118408,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1",
            "probability": 0.06119131023445582,
            "start_logit": 5.614424228668213,
            "end_logit": 4.2405266761779785,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6",
            "probability": 0.05283237080535498,
            "start_logit": 5.614424228668213,
            "end_logit": 4.0936455726623535,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6) and SBF (Swi4",
            "probability": 0.05140527320849735,
            "start_logit": 5.351279258728027,
            "end_logit": 4.329407215118408,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (Swi4",
            "probability": 0.04749545162037477,
            "start_logit": 5.272172451019287,
            "end_logit": 4.329407215118408,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1",
            "probability": 0.047033504989927664,
            "start_logit": 5.351279258728027,
            "end_logit": 4.2405266761779785,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and SBF",
            "probability": 0.04581142726133844,
            "start_logit": 4.860081672668457,
            "end_logit": 4.705397605895996,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "MBF (Mbp1/Swi6) and SBF (Swi4/Swi6",
            "probability": 0.04262464835186977,
            "start_logit": 5.614424228668213,
            "end_logit": 3.8789541721343994,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6",
            "probability": 0.04060856952371924,
            "start_logit": 5.351279258728027,
            "end_logit": 4.0936455726623535,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Mbp1/Swi6) and SBF (Swi4/Swi6",
            "probability": 0.0327626031093336,
            "start_logit": 5.351279258728027,
            "end_logit": 3.8789541721343994,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4",
            "probability": 0.03158125864076648,
            "start_logit": 4.864102363586426,
            "end_logit": 4.329407215118408,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and SBF (Swi4",
            "probability": 0.03145453508980399,
            "start_logit": 4.860081672668457,
            "end_logit": 4.329407215118408,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "SBF (Swi4/Swi6",
            "probability": 0.030270719982861075,
            "start_logit": 5.272172451019287,
            "end_logit": 3.8789541721343994,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6",
            "probability": 0.024848105949166092,
            "start_logit": 4.860081672668457,
            "end_logit": 4.0936455726623535,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi4/Swi6",
            "probability": 0.02012797866755837,
            "start_logit": 4.864102363586426,
            "end_logit": 3.8789541721343994,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        },
        {
            "text": "Swi6) and SBF (Swi4/Swi6",
            "probability": 0.020047212762707513,
            "start_logit": 4.860081672668457,
            "end_logit": 3.8789541721343994,
            "question_text": "Which are the main G1/S transcription factors in yeast?"
        }
    ],
    "5e30ee25fbd6abf43b00003f": [
        {
            "text": "multiple Allergies",
            "probability": 0.16923591854294978,
            "start_logit": 4.6833977699279785,
            "end_logit": 5.7132248878479,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis",
            "probability": 0.13621370830457089,
            "start_logit": 4.240811824798584,
            "end_logit": 5.938742160797119,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis",
            "probability": 0.11341912233174811,
            "start_logit": 4.057676792144775,
            "end_logit": 5.938742160797119,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple Allergies, Metabolic wasting",
            "probability": 0.11198309941184038,
            "start_logit": 4.6833977699279785,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Metabolic wasting",
            "probability": 0.11078844297583895,
            "start_logit": 4.672672271728516,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies",
            "probability": 0.10871260666119874,
            "start_logit": 4.240811824798584,
            "end_logit": 5.7132248878479,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies",
            "probability": 0.09052017295014028,
            "start_logit": 4.057676792144775,
            "end_logit": 5.7132248878479,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies, Metabolic wasting",
            "probability": 0.07193493404871809,
            "start_logit": 4.240811824798584,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies, Metabolic wasting",
            "probability": 0.05989703375929609,
            "start_logit": 4.057676792144775,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Allergies",
            "probability": 0.009418868236554615,
            "start_logit": 1.7948189973831177,
            "end_logit": 5.7132248878479,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Allergies, Metabolic wasting",
            "probability": 0.0062324479765413325,
            "start_logit": 1.7948189973831177,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis,",
            "probability": 0.002067317792264042,
            "start_logit": 4.240811824798584,
            "end_logit": 1.7507691383361816,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "multiple Allergies,",
            "probability": 0.002061413321696019,
            "start_logit": 4.6833977699279785,
            "end_logit": 1.3053230047225952,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis,",
            "probability": 0.0017213639691470517,
            "start_logit": 4.057676792144775,
            "end_logit": 1.7507691383361816,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "dermatitis, multiple Allergies,",
            "probability": 0.0013241965271741088,
            "start_logit": 4.240811824798584,
            "end_logit": 1.3053230047225952,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "(Severe dermatitis",
            "probability": 0.0011180636531867387,
            "start_logit": -0.5618149042129517,
            "end_logit": 5.938742160797119,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "Severe dermatitis, multiple Allergies,",
            "probability": 0.0011025998027380365,
            "start_logit": 4.057676792144775,
            "end_logit": 1.3053230047225952,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "(Severe dermatitis, multiple Allergies",
            "probability": 0.0008923302629665954,
            "start_logit": -0.5618149042129517,
            "end_logit": 5.7132248878479,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "wasting",
            "probability": 0.0007659061598263801,
            "start_logit": -0.30164581537246704,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        },
        {
            "text": "(Severe dermatitis, multiple Allergies, Metabolic wasting",
            "probability": 0.0005904533116037191,
            "start_logit": -0.5618149042129517,
            "end_logit": 5.300279140472412,
            "question_text": "List features of the SAM syndrome."
        }
    ],
    "5e46f9683f54159529000010": [
        {
            "text": "reducing side effects",
            "probability": 0.23681869002166175,
            "start_logit": -4.681434631347656,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "cancer there needs to be ongoing research to ensure that radiation therapy targets the tumour effectively and minimises potential side effects",
            "probability": 0.10650353913063186,
            "start_logit": -4.973545074462891,
            "end_logit": -4.355616092681885,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "tumour effectively and minimises potential side effects",
            "probability": 0.0757900353634676,
            "start_logit": -5.313756465911865,
            "end_logit": -4.355616092681885,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects. Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.07355029630332148,
            "start_logit": -5.850759983062744,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "cancer",
            "probability": 0.06225260911288895,
            "start_logit": -4.973545074462891,
            "end_logit": -4.892593860626221,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "potential side effects. Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.05280016126260768,
            "start_logit": -6.182215213775635,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "minimises potential side effects",
            "probability": 0.04429905332885793,
            "start_logit": -5.850759983062744,
            "end_logit": -4.355616092681885,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "side effects",
            "probability": 0.0381322358553619,
            "start_logit": -6.507669448852539,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing side effects and improving cancer control",
            "probability": 0.03539072487186018,
            "start_logit": -4.681434631347656,
            "end_logit": -5.749454975128174,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "side effects. Major advances in radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.033035494355443736,
            "start_logit": -6.65114688873291,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.03283317630327742,
            "start_logit": -6.657289981842041,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "potential side effects",
            "probability": 0.03180132884711341,
            "start_logit": -6.182215213775635,
            "end_logit": -4.355616092681885,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation therapy targets the tumour effectively and minimises potential side effects",
            "probability": 0.029618079043849974,
            "start_logit": -6.25333833694458,
            "end_logit": -4.355616092681885,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "reducing",
            "probability": 0.028564968577836986,
            "start_logit": -4.681434631347656,
            "end_logit": -5.963723659515381,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "tumour effectively and minimises potential side effects. Major advances in radiation therapy,",
            "probability": 0.026206202350019987,
            "start_logit": -5.313756465911865,
            "end_logit": -5.417586803436279,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "cancer there needs to be ongoing research to ensure that radiation therapy targets the tumour effectively",
            "probability": 0.022483338110448513,
            "start_logit": -4.973545074462891,
            "end_logit": -5.911019802093506,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.018525728588398648,
            "start_logit": -7.229568958282471,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "effects",
            "probability": 0.017868290972508964,
            "start_logit": -7.265701770782471,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation therapy, due to improvements in engineering and computing, have made it more precise, reducing side effects",
            "probability": 0.017117974177852126,
            "start_logit": -7.308600425720215,
            "end_logit": -3.8486099243164062,
            "question_text": "List side effects of radiation therapy?"
        },
        {
            "text": "radiation therapy is needed by approximately 50% of patients with cancer",
            "probability": 0.01640807342259072,
            "start_logit": -6.306972026824951,
            "end_logit": -4.892593860626221,
            "question_text": "List side effects of radiation therapy?"
        }
    ],
    "5e4027f948dab47f2600000d": [
        {
            "text": "meningitis",
            "probability": 0.8269118283280236,
            "start_logit": 4.394346237182617,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and meningitis",
            "probability": 0.15593558141765812,
            "start_logit": 2.726091146469116,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia",
            "probability": 0.01398665887476933,
            "start_logit": 2.726091146469116,
            "end_logit": 1.9104769229888916,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis",
            "probability": 0.0009119181216900181,
            "start_logit": -2.4155569076538086,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis",
            "probability": 0.000866142469896673,
            "start_logit": -2.467057704925537,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "men",
            "probability": 0.0005625626374947131,
            "start_logit": 4.394346237182617,
            "end_logit": -2.971134901046753,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis. The PHAT can be used as an auxiliary method of diagnosis permitting to establish the meningococcus",
            "probability": 0.00023364624256333303,
            "start_logit": 4.394346237182617,
            "end_logit": -3.8498291969299316,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia and meningitis",
            "probability": 0.00021722064068664828,
            "start_logit": -3.850193500518799,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningitis.",
            "probability": 0.0001712830719420938,
            "start_logit": 4.394346237182617,
            "end_logit": -4.160319805145264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and men",
            "probability": 0.00010608571428825991,
            "start_logit": 2.726091146469116,
            "end_logit": -2.971134901046753,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia and meningitis",
            "probability": 4.049742986990303e-05,
            "start_logit": -5.5298686027526855,
            "end_logit": 4.3218159675598145,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "meningococciemia and meningitis.",
            "probability": 3.2299846846183764e-05,
            "start_logit": 2.726091146469116,
            "end_logit": -4.160319805145264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia",
            "probability": 1.948362890766728e-05,
            "start_logit": -3.850193500518799,
            "end_logit": 1.9104769229888916,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "antibody titre was mose frequent in the patients with clinical manifestations of meningococciemia",
            "probability": 3.6324213610883163e-06,
            "start_logit": -5.5298686027526855,
            "end_logit": 1.9104769229888916,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis. The PHAT can be used as an auxiliary method of diagnosis permitting to establish the meningococcus",
            "probability": 2.576650077543271e-07,
            "start_logit": -2.4155569076538086,
            "end_logit": -3.8498291969299316,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis. The PHAT can be used as an auxiliary method of diagnosis permitting to establish the meningococcus",
            "probability": 2.447309697154373e-07,
            "start_logit": -2.467057704925537,
            "end_logit": -3.8498291969299316,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "ingitis.",
            "probability": 1.8889092148863266e-07,
            "start_logit": -2.4155569076538086,
            "end_logit": -4.160319805145264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "itis.",
            "probability": 1.794091436367315e-07,
            "start_logit": -2.467057704925537,
            "end_logit": -4.160319805145264,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "mia and men",
            "probability": 1.4777901628285482e-07,
            "start_logit": -3.850193500518799,
            "end_logit": -2.971134901046753,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        },
        {
            "text": "passive hemagglutination",
            "probability": 1.4067894335384435e-07,
            "start_logit": -2.9191577434539795,
            "end_logit": -3.9514083862304688,
            "question_text": "List diseases that are caused by the Meningococcus B?"
        }
    ],
    "5e5015436d0a277941000037": [
        {
            "text": "MobiDB",
            "probability": 0.9775253243157421,
            "start_logit": 4.2191267013549805,
            "end_logit": 3.705430746078491,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is the main repository of protein disorder and mobility annotations,",
            "probability": 0.008121494105189926,
            "start_logit": 4.2191267013549805,
            "end_logit": -1.085079312324524,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB, emphasizing how to use and access the intrinsic disorder data. MobiDB",
            "probability": 0.003720467717549777,
            "start_logit": 2.2583112716674805,
            "end_logit": 0.09507136791944504,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is",
            "probability": 0.003489137392817597,
            "start_logit": 4.2191267013549805,
            "end_logit": -1.9299389123916626,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "Mob",
            "probability": 0.0018054217382065501,
            "start_logit": 4.2191267013549805,
            "end_logit": -2.588799238204956,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB, emphasizing how to use and access the intrinsic disorder data. MobiDB is available at URL http://mobidb",
            "probability": 0.0016093788005032705,
            "start_logit": 2.2583112716674805,
            "end_logit": -0.7429297566413879,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiD",
            "probability": 0.0008494808193098166,
            "start_logit": 4.2191267013549805,
            "end_logit": -3.3427233695983887,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB,",
            "probability": 0.0008475280258127973,
            "start_logit": 2.2583112716674805,
            "end_logit": -1.384209394454956,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is the main repository of protein disorder and mobility annotations",
            "probability": 0.0006281621967305791,
            "start_logit": 4.2191267013549805,
            "end_logit": -3.644550323486328,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is the main repository",
            "probability": 0.0004940158538310272,
            "start_logit": 4.2191267013549805,
            "end_logit": -3.8847811222076416,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is the",
            "probability": 0.00022348429183456991,
            "start_logit": 4.2191267013549805,
            "end_logit": -4.67800760269165,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB is available at URL http://mobidb",
            "probability": 0.0002069806482077454,
            "start_logit": 0.2073330283164978,
            "end_logit": -0.7429297566413879,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "mobidb",
            "probability": 0.0001852096884975964,
            "start_logit": 0.09619636088609695,
            "end_logit": -0.7429297566413879,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "b",
            "probability": 0.00014162959367584746,
            "start_logit": -4.6204376220703125,
            "end_logit": 3.705430746078491,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB, emphasizing how to use and access the intrinsic disorder data.",
            "probability": 5.6437012553318826e-05,
            "start_logit": 2.2583112716674805,
            "end_logit": -4.093408107757568,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB, emphasizing how to use and access the intrinsic disorder data. MobiDB is available at URL http://mob",
            "probability": 2.9684691327037963e-05,
            "start_logit": 2.2583112716674805,
            "end_logit": -4.735901832580566,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "MobiDB, emphasizing how to use and access the intrinsic disorder data. Mob",
            "probability": 2.0960825886422564e-05,
            "start_logit": 2.2583112716674805,
            "end_logit": -5.083878040313721,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "the main repository of protein disorder and mobility annotations, combining different data sources to provide an exhaustive overview of intrinsic disorder. MobiDB",
            "probability": 1.8558990210914123e-05,
            "start_logit": -3.875235080718994,
            "end_logit": 0.927967369556427,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "main repository of protein disorder and mobility annotations, combining different data sources to provide an exhaustive overview of intrinsic disorder. MobiDB",
            "probability": 1.4700031157317704e-05,
            "start_logit": -4.108339786529541,
            "end_logit": 0.927967369556427,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        },
        {
            "text": "This chapter describes the data available in MobiDB",
            "probability": 1.1943260956175635e-05,
            "start_logit": -4.842298984527588,
            "end_logit": 1.4542441368103027,
            "question_text": "Which are the databases for intrinsic protein disorders?"
        }
    ],
    "5e4f0a4f6d0a277941000031": [
        {
            "text": "immunoglobulin heavy chain gene",
            "probability": 0.2382755345039332,
            "start_logit": -0.6500119566917419,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity",
            "probability": 0.1706471562684994,
            "start_logit": -1.463197946548462,
            "end_logit": -1.352806568145752,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity of the immunoglobulin heavy chain gene",
            "probability": 0.10566161982788692,
            "start_logit": -1.463197946548462,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "immunoglobulin heavy chain gene (",
            "probability": 0.10417513980312902,
            "start_logit": -0.6500119566917419,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the diversity",
            "probability": 0.057426931653173835,
            "start_logit": -2.5522825717926025,
            "end_logit": -1.352806568145752,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity of the immunoglobulin heavy chain gene (",
            "probability": 0.046195737385759564,
            "start_logit": -1.463197946548462,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "heavy chain gene",
            "probability": 0.04477897041935166,
            "start_logit": -2.3217010498046875,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "im",
            "probability": 0.0446472847600379,
            "start_logit": -0.6500119566917419,
            "end_logit": -3.5067970752716064,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the diversity of the immunoglobulin heavy chain gene",
            "probability": 0.03555771307827992,
            "start_logit": -2.5522825717926025,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "immunoglobulin heavy",
            "probability": 0.028268117720757543,
            "start_logit": -0.6500119566917419,
            "end_logit": -3.9638559818267822,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity of the im",
            "probability": 0.019798526267012378,
            "start_logit": -1.463197946548462,
            "end_logit": -3.5067970752716064,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "heavy chain gene (",
            "probability": 0.01957756810151709,
            "start_logit": -2.3217010498046875,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the immunoglobulin heavy chain gene",
            "probability": 0.017424888290484376,
            "start_logit": -3.26554012298584,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the diversity of the immunoglobulin heavy chain gene (",
            "probability": 0.01554599274625996,
            "start_logit": -2.5522825717926025,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gene",
            "probability": 0.013839494176767126,
            "start_logit": -3.49591326713562,
            "end_logit": -1.832162857055664,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "diversity of the immunoglobulin heavy",
            "probability": 0.012535299161447619,
            "start_logit": -1.463197946548462,
            "end_logit": -3.9638559818267822,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the immunoglobulin heavy chain gene (",
            "probability": 0.007618239856199553,
            "start_logit": -3.26554012298584,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "the diversity of the im",
            "probability": 0.006662687147158543,
            "start_logit": -2.5522825717926025,
            "end_logit": -3.5067970752716064,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "gene (",
            "probability": 0.0060506893570540145,
            "start_logit": -3.49591326713562,
            "end_logit": -2.6595170497894287,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        },
        {
            "text": "heavy",
            "probability": 0.005312409475290287,
            "start_logit": -2.3217010498046875,
            "end_logit": -3.9638559818267822,
            "question_text": "List the 5 different human immunoglobulin heavy chains."
        }
    ],
    "5e55046fb761aafe09000004": [
        {
            "text": "fezolinetant",
            "probability": 0.9605610783504862,
            "start_logit": 3.141723155975342,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "f",
            "probability": 0.008750921722903864,
            "start_logit": 3.141723155975342,
            "end_logit": -3.016935110092163,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolin",
            "probability": 0.006063407537648162,
            "start_logit": 3.141723155975342,
            "end_logit": -3.383822202682495,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolineta",
            "probability": 0.004309436633436354,
            "start_logit": 3.141723155975342,
            "end_logit": -3.7252869606018066,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "triazolopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.00418478560316203,
            "start_logit": -2.2943389415740967,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized. An isoxazolo[3,4-c]piperidine",
            "probability": 0.003141189916756328,
            "start_logit": 3.141723155975342,
            "end_logit": -4.041492462158203,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fez",
            "probability": 0.003040052903814074,
            "start_logit": 3.141723155975342,
            "end_logit": -4.074219226837158,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized.",
            "probability": 0.002326631990439574,
            "start_logit": 3.141723155975342,
            "end_logit": -4.341672420501709,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized. An is",
            "probability": 0.0015822476978353125,
            "start_logit": 3.141723155975342,
            "end_logit": -4.727247714996338,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "nt",
            "probability": 0.0013793330143034373,
            "start_logit": -3.4041943550109863,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized. An isoxazolo",
            "probability": 0.0010186068044702793,
            "start_logit": 3.141723155975342,
            "end_logit": -5.16765832901001,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "fezolinetant were designed and synthesized. An isoxazolo[3,4-c]piperidine derivative",
            "probability": 0.0009587587233160726,
            "start_logit": 3.141723155975342,
            "end_logit": -5.228209972381592,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "azine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.000582479410360897,
            "start_logit": -4.266255855560303,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "zolopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.0004457948033356357,
            "start_logit": -4.533690929412842,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "lopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.0003787201803500023,
            "start_logit": -4.696752071380615,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "etant",
            "probability": 0.00033717238031772344,
            "start_logit": -4.812955379486084,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "antagonist fezolinetant",
            "probability": 0.0003095079951181934,
            "start_logit": -4.898565769195557,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "olinetant",
            "probability": 0.00024204226998800383,
            "start_logit": -5.144437313079834,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "ne substructure in an NK3R antagonist fezolinetant",
            "probability": 0.00023221547089165786,
            "start_logit": -5.18588399887085,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        },
        {
            "text": "riazolopiperazine substructure in an NK3R antagonist fezolinetant",
            "probability": 0.00015561659106604035,
            "start_logit": -5.586154460906982,
            "end_logit": 1.6814234256744385,
            "question_text": "List 3 NK3R antagonists."
        }
    ],
    "5e494b0e6d0a277941000007": [
        {
            "text": "six",
            "probability": 0.11356697702305277,
            "start_logit": -5.1355881690979,
            "end_logit": -5.056437015533447,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no",
            "probability": 0.11228413746585876,
            "start_logit": -4.70154333114624,
            "end_logit": -5.501842021942139,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no small-molecule inhibitors have been approved so far,",
            "probability": 0.10874221524071509,
            "start_logit": -4.70154333114624,
            "end_logit": -5.5338945388793945,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six",
            "probability": 0.10426670974165465,
            "start_logit": -5.221028804779053,
            "end_logit": -5.056437015533447,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16",
            "probability": 0.08279778974508918,
            "start_logit": -5.221028804779053,
            "end_logit": -5.286987781524658,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no small-molecule inhibitors",
            "probability": 0.07405910079115405,
            "start_logit": -4.70154333114624,
            "end_logit": -5.91801118850708,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no small-molecule inhibitors have been approved",
            "probability": 0.06910134715586522,
            "start_logit": -4.70154333114624,
            "end_logit": -5.987300395965576,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "no small-molecule inhibitors have been approved so far",
            "probability": 0.058204098005142486,
            "start_logit": -4.70154333114624,
            "end_logit": -6.158918857574463,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies",
            "probability": 0.03804768263848587,
            "start_logit": -5.1355881690979,
            "end_logit": -6.149989604949951,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies",
            "probability": 0.03493186827720459,
            "start_logit": -5.221028804779053,
            "end_logit": -6.149989604949951,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "launch of six",
            "probability": 0.024856090135941145,
            "start_logit": -6.65487813949585,
            "end_logit": -5.056437015533447,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "leading to 16 clinical candidates and the launch of six",
            "probability": 0.023559299057048066,
            "start_logit": -6.708460330963135,
            "end_logit": -5.056437015533447,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs",
            "probability": 0.02346404849476302,
            "start_logit": -5.1355881690979,
            "end_logit": -6.633360385894775,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs",
            "probability": 0.02154252228859583,
            "start_logit": -5.221028804779053,
            "end_logit": -6.633360385894775,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "peptide-based and non-peptide small-molecule inhibitors as potential alternatives or supplements to mAbs. However, no",
            "probability": 0.0208398919044747,
            "start_logit": -6.385706901550293,
            "end_logit": -5.501842021942139,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "six monoclonal antibodies (mAbs) drugs.",
            "probability": 0.020673002082629423,
            "start_logit": -5.1355881690979,
            "end_logit": -6.760001182556152,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates and the launch of six monoclonal antibodies (mAbs) drugs.",
            "probability": 0.018980041242099822,
            "start_logit": -5.221028804779053,
            "end_logit": -6.760001182556152,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "leading to 16",
            "probability": 0.01870834799237799,
            "start_logit": -6.708460330963135,
            "end_logit": -5.286987781524658,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "small-molecule inhibitors have been approved so far,",
            "probability": 0.015783603878426308,
            "start_logit": -6.631551742553711,
            "end_logit": -5.5338945388793945,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        },
        {
            "text": "16 clinical candidates",
            "probability": 0.01559122683942101,
            "start_logit": -5.221028804779053,
            "end_logit": -6.956680774688721,
            "question_text": "List 3 PD-L1 inhibitors on the market as of 2018."
        }
    ],
    "5e4be9496d0a27794100002a": [
        {
            "text": "TKIs",
            "probability": 0.33725953573433887,
            "start_logit": 3.6978659629821777,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors (TKIs",
            "probability": 0.2752314486279774,
            "start_logit": 3.4946255683898926,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors",
            "probability": 0.13429530132726827,
            "start_logit": 3.4946255683898926,
            "end_logit": 3.5264511108398438,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors (TKIs",
            "probability": 0.05529979687745744,
            "start_logit": 1.889782428741455,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitor",
            "probability": 0.053319336986961716,
            "start_logit": 3.4946255683898926,
            "end_logit": 2.6027090549468994,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitors (TKIs",
            "probability": 0.034743428787270374,
            "start_logit": 1.4250036478042603,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors",
            "probability": 0.026982755502744427,
            "start_logit": 1.889782428741455,
            "end_logit": 3.5264511108398438,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "TKIs)",
            "probability": 0.02013999209009404,
            "start_logit": 3.6978659629821777,
            "end_logit": 1.4258770942687988,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitors",
            "probability": 0.01695256578195648,
            "start_logit": 1.4250036478042603,
            "end_logit": 3.5264511108398438,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "tyrosine kinase inhibitors (TKIs)",
            "probability": 0.016435885752623947,
            "start_logit": 3.4946255683898926,
            "end_logit": 1.4258770942687988,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitor",
            "probability": 0.010712978185153384,
            "start_logit": 1.889782428741455,
            "end_logit": 2.6027090549468994,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitor",
            "probability": 0.006730686470698133,
            "start_logit": 1.4250036478042603,
            "end_logit": 2.6027090549468994,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "inhibitors (TKIs)",
            "probability": 0.0033023157351823452,
            "start_logit": 1.889782428741455,
            "end_logit": 1.4258770942687988,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "kinase inhibitors (TKIs)",
            "probability": 0.0020747593672475243,
            "start_logit": 1.4250036478042603,
            "end_logit": 1.4258770942687988,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "(TKIs",
            "probability": 0.002051834268737798,
            "start_logit": -1.4042526483535767,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "variety of tyrosine kinase inhibitors (TKIs",
            "probability": 0.0018864911147349337,
            "start_logit": -1.488268256187439,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "variety of tyrosine kinase inhibitors",
            "probability": 0.0009204867175152796,
            "start_logit": -1.488268256187439,
            "end_logit": 3.5264511108398438,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "KIs",
            "probability": 0.0007947162308266978,
            "start_logit": -2.352756977081299,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "Although a variety of tyrosine kinase inhibitors (TKIs",
            "probability": 0.000500223095965425,
            "start_logit": -2.815687894821167,
            "end_logit": 4.244022369384766,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        },
        {
            "text": "variety of tyrosine kinase inhibitor",
            "probability": 0.000365461345245546,
            "start_logit": -1.488268256187439,
            "end_logit": 2.6027090549468994,
            "question_text": "Please list 3 drugs that have EGFR as their primary target."
        }
    ],
    "5d36a9507bc3fee31f000005": [
        {
            "text": "human T\u00a0cells",
            "probability": 0.4643826325076649,
            "start_logit": -1.9486552476882935,
            "end_logit": -2.10579514503479,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T\u00a0cells",
            "probability": 0.3859694194410687,
            "start_logit": -2.13360595703125,
            "end_logit": -2.10579514503479,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "functional human T\u00a0cells",
            "probability": 0.026811638071197068,
            "start_logit": -4.800528049468994,
            "end_logit": -2.10579514503479,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human T\u00a0cells that have matured in the presence of human self-peptides and human leukocyte antigen molecules.",
            "probability": 0.018090567630667333,
            "start_logit": -1.9486552476882935,
            "end_logit": -5.351113319396973,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human T\u00a0cells that have matured in the presence of human self-peptides and human leukocyte antigen molecules. Neonatal",
            "probability": 0.015039910296188955,
            "start_logit": -1.9486552476882935,
            "end_logit": -5.535796642303467,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T\u00a0cells that have matured in the presence of human self-peptides and human leukocyte antigen molecules.",
            "probability": 0.015035889365765227,
            "start_logit": -2.13360595703125,
            "end_logit": -5.351113319396973,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T\u00a0cells that have matured in the presence of human self-peptides and human leukocyte antigen molecules. Neonatal",
            "probability": 0.012500350011194676,
            "start_logit": -2.13360595703125,
            "end_logit": -5.535796642303467,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human T\u00a0cells that have matured in the presence of human self-peptides",
            "probability": 0.01078379745236422,
            "start_logit": -1.9486552476882935,
            "end_logit": -5.868459224700928,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "T\u00a0cells that have matured in the presence of human self-peptides",
            "probability": 0.008962902035296065,
            "start_logit": -2.13360595703125,
            "end_logit": -5.868459224700928,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human",
            "probability": 0.008889805925963482,
            "start_logit": -1.9486552476882935,
            "end_logit": -6.061598777770996,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells",
            "probability": 0.007171576350516102,
            "start_logit": -3.80110502243042,
            "end_logit": -4.423928737640381,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "stem cells",
            "probability": 0.003928601686088625,
            "start_logit": -4.402946949005127,
            "end_logit": -4.423928737640381,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells (HSCs)",
            "probability": 0.003625069838227224,
            "start_logit": -3.80110502243042,
            "end_logit": -5.106180667877197,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem",
            "probability": 0.0035548461536138733,
            "start_logit": -3.80110502243042,
            "end_logit": -5.125742435455322,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "hematopoietic stem cells (HSCs). Conventional humanized mouse models are made by engrafting human fetal thymus",
            "probability": 0.003019949634336026,
            "start_logit": -3.80110502243042,
            "end_logit": -5.288814067840576,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human leukocyte antigen molecules. Neonatal thymus",
            "probability": 0.0027753101059184607,
            "start_logit": -3.9980523586273193,
            "end_logit": -5.176344394683838,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human leukocyte antigen molecules. Neonatal thymus tissue is more abundant and developmentally mature",
            "probability": 0.0026644233856570007,
            "start_logit": -3.9980523586273193,
            "end_logit": -5.217119216918945,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human leukocyte antigen molecules. Neonatal thymus tissue",
            "probability": 0.0024771987397410023,
            "start_logit": -3.9980523586273193,
            "end_logit": -5.289978504180908,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "human leukocyte antigen molecules",
            "probability": 0.0023302919638999255,
            "start_logit": -3.9980523586273193,
            "end_logit": -5.351113319396973,
            "question_text": "Which cells mature in the human thymus?"
        },
        {
            "text": "stem cells (HSCs)",
            "probability": 0.0019858194046311175,
            "start_logit": -4.402946949005127,
            "end_logit": -5.106180667877197,
            "question_text": "Which cells mature in the human thymus?"
        }
    ],
    "5e30f8abfbd6abf43b000047": [
        {
            "text": "FMS-like tyrosine kinase 3",
            "probability": 0.3929673547314744,
            "start_logit": 5.95929479598999,
            "end_logit": 5.112267017364502,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3",
            "probability": 0.2347674723380964,
            "start_logit": 5.95929479598999,
            "end_logit": 4.5971360206604,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS",
            "probability": 0.11474721767134811,
            "start_logit": 5.95929479598999,
            "end_logit": 3.881272077560425,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3",
            "probability": 0.09313817211488194,
            "start_logit": 5.034783363342285,
            "end_logit": 4.5971360206604,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3)",
            "probability": 0.06770754313645819,
            "start_logit": 5.95929479598999,
            "end_logit": 3.3537380695343018,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3)",
            "probability": 0.026861288505238622,
            "start_logit": 5.034783363342285,
            "end_logit": 3.3537380695343018,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor",
            "probability": 0.01726439749815658,
            "start_logit": 5.95929479598999,
            "end_logit": 1.9871869087219238,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor, were confirmed in AML cells with FLT3",
            "probability": 0.013166555011835078,
            "start_logit": 5.95929479598999,
            "end_logit": 1.7162203788757324,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3",
            "probability": 0.006994943144271019,
            "start_logit": 1.9307557344436646,
            "end_logit": 5.112267017364502,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3) inhibitor",
            "probability": 0.006849221528131237,
            "start_logit": 5.034783363342285,
            "end_logit": 1.9871869087219238,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FLT3) inhibitor, were confirmed in AML cells with FLT3",
            "probability": 0.005223504153447242,
            "start_logit": 5.034783363342285,
            "end_logit": 1.7162203788757324,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3 (FLT3",
            "probability": 0.004178935225424399,
            "start_logit": 1.9307557344436646,
            "end_logit": 4.5971360206604,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase",
            "probability": 0.003878234865953923,
            "start_logit": 5.95929479598999,
            "end_logit": 0.49392059445381165,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "(FLT3",
            "probability": 0.003797673054423741,
            "start_logit": 1.835087776184082,
            "end_logit": 4.5971360206604,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3",
            "probability": 0.0022078888828464126,
            "start_logit": 0.7776050567626953,
            "end_logit": 5.112267017364502,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "FMS-like tyrosine kinase 3 (FLT3) inhibitor,",
            "probability": 0.0016492869211569411,
            "start_logit": 5.95929479598999,
            "end_logit": -0.361116498708725,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "kinase 3 (FLT3",
            "probability": 0.0013190421188636196,
            "start_logit": 0.7776050567626953,
            "end_logit": 4.5971360206604,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "tyrosine kinase 3 (FLT3)",
            "probability": 0.001205215672435268,
            "start_logit": 1.9307557344436646,
            "end_logit": 3.3537380695343018,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "(FLT3)",
            "probability": 0.001095258681237822,
            "start_logit": 1.835087776184082,
            "end_logit": 3.3537380695343018,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        },
        {
            "text": "3",
            "probability": 0.0009807947443186405,
            "start_logit": -0.03382381796836853,
            "end_logit": 5.112267017364502,
            "question_text": "Which molecules are inhibited by Gilteritinib?"
        }
    ],
    "5e4163b848dab47f2600000f": [
        {
            "text": "influenza",
            "probability": 0.6008039097983509,
            "start_logit": 2.4525527954101562,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenoviridae. The influenza",
            "probability": 0.17658313650167767,
            "start_logit": 1.2280759811401367,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenoviridae. The influenza",
            "probability": 0.08134146322075476,
            "start_logit": 0.45294007658958435,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "influenza viruses",
            "probability": 0.04003080376734047,
            "start_logit": 2.4525527954101562,
            "end_logit": -1.0413672924041748,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "adenoviridae. The influenza",
            "probability": 0.017426226561122197,
            "start_logit": -1.0877394676208496,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronavir",
            "probability": 0.016543841368284403,
            "start_logit": 1.2280759811401367,
            "end_logit": -0.7005258202552795,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenoviridae. The influenza viruses",
            "probability": 0.011765510794183514,
            "start_logit": 1.2280759811401367,
            "end_logit": -1.0413672924041748,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae",
            "probability": 0.010461369922842866,
            "start_logit": 1.2280759811401367,
            "end_logit": -1.1588503122329712,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronavir",
            "probability": 0.007620774502300914,
            "start_logit": 0.45294007658958435,
            "end_logit": -0.7005258202552795,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "pneumonia",
            "probability": 0.00660376193997842,
            "start_logit": -0.3710388243198395,
            "end_logit": -0.019785447046160698,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenoviridae. The influenza viruses",
            "probability": 0.005419678699213608,
            "start_logit": 0.45294007658958435,
            "end_logit": -1.0413672924041748,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae",
            "probability": 0.004971764383449889,
            "start_logit": 0.45294007658958435,
            "end_logit": -1.127629041671753,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae",
            "probability": 0.00481893771781287,
            "start_logit": 0.45294007658958435,
            "end_logit": -1.1588503122329712,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenoviridae",
            "probability": 0.0035296717092166466,
            "start_logit": 1.2280759811401367,
            "end_logit": -2.2453348636627197,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "The influenza",
            "probability": 0.0024931570737953784,
            "start_logit": -3.032166004180908,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "influenza viruses,",
            "probability": 0.0023423371876388215,
            "start_logit": 2.4525527954101562,
            "end_logit": -3.8798673152923584,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "coronaviridae, and adenovir",
            "probability": 0.002042193452838548,
            "start_logit": 1.2280759811401367,
            "end_logit": -2.792515277862549,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "fluenza",
            "probability": 0.0019768230679971617,
            "start_logit": -3.2642247676849365,
            "end_logit": 1.6672520637512207,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "picornaviridae, coronaviridae, and adenoviridae",
            "probability": 0.0016259121182495063,
            "start_logit": 0.45294007658958435,
            "end_logit": -2.2453348636627197,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        },
        {
            "text": "influenza viruses, which consist of types A, B, and C, belong to the family orthomyxoviridae.",
            "probability": 0.0015987262129516895,
            "start_logit": 2.4525527954101562,
            "end_logit": -4.261809349060059,
            "question_text": "List 3 human diseases caused by  viruses in the family Paramyxoviridae."
        }
    ],
    "5e342175fbd6abf43b000064": [
        {
            "text": "anorectal anomalies",
            "probability": 0.20481261861084626,
            "start_logit": 5.200164318084717,
            "end_logit": 5.55871057510376,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal anomalies, and a presacral mass",
            "probability": 0.16664683057076207,
            "start_logit": 5.200164318084717,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal anomalies",
            "probability": 0.12288692533927989,
            "start_logit": 4.689333438873291,
            "end_logit": 5.55871057510376,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal anomalies, and a presacral mass",
            "probability": 0.09998757286184307,
            "start_logit": 4.689333438873291,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "presacral mass",
            "probability": 0.09336181657941285,
            "start_logit": 4.62076997756958,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis",
            "probability": 0.08839715344470221,
            "start_logit": 4.689333438873291,
            "end_logit": 5.229285717010498,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "partial sacral agenesis, anorectal anomalies",
            "probability": 0.060423584825924324,
            "start_logit": 3.9794483184814453,
            "end_logit": 5.55871057510376,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "partial sacral agenesis, anorectal anomalies, and a presacral mass",
            "probability": 0.04916395762751424,
            "start_logit": 3.9794483184814453,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "partial sacral agenesis",
            "probability": 0.043464940511689365,
            "start_logit": 3.9794483184814453,
            "end_logit": 5.229285717010498,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "a presacral mass",
            "probability": 0.030468309880992712,
            "start_logit": 3.500974655151367,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "agenesis, anorectal anomalies",
            "probability": 0.009832158283764984,
            "start_logit": 2.163727283477783,
            "end_logit": 5.55871057510376,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "agenesis, anorectal anomalies, and a presacral mass",
            "probability": 0.007999985678483623,
            "start_logit": 2.163727283477783,
            "end_logit": 5.352491855621338,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "agenesis",
            "probability": 0.0070726385423263635,
            "start_logit": 2.163727283477783,
            "end_logit": 5.229285717010498,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis,",
            "probability": 0.003427418463803076,
            "start_logit": 4.689333438873291,
            "end_logit": 1.9792532920837402,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal anomalies,",
            "probability": 0.0034089360996963315,
            "start_logit": 5.200164318084717,
            "end_logit": 1.4630153179168701,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anorectal anomalies, and a presacral mass.",
            "probability": 0.002108000000759943,
            "start_logit": 5.200164318084717,
            "end_logit": 0.9823547005653381,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal anomalies,",
            "probability": 0.0020453509105594465,
            "start_logit": 4.689333438873291,
            "end_logit": 1.4630153179168701,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "partial sacral agenesis,",
            "probability": 0.0016852639913462575,
            "start_logit": 3.9794483184814453,
            "end_logit": 1.9792532920837402,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "anomalies",
            "probability": 0.0015417444229071143,
            "start_logit": 0.3109833300113678,
            "end_logit": 5.55871057510376,
            "question_text": "List features of the Currarino triad."
        },
        {
            "text": "sacral agenesis, anorectal anomalies, and a presacral mass.",
            "probability": 0.0012647933533860437,
            "start_logit": 4.689333438873291,
            "end_logit": 0.9823547005653381,
            "question_text": "List features of the Currarino triad."
        }
    ],
    "5e36a901b5b409ea53000005": [
        {
            "text": "transcribed ultraconserved region",
            "probability": 0.24982256461444333,
            "start_logit": -1.6964576244354248,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved region (T-UCR) biomarkers",
            "probability": 0.19351024908958478,
            "start_logit": -1.6964576244354248,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved region (T-UCR) biomarkers related to LCXW.",
            "probability": 0.07506248608732705,
            "start_logit": -1.6964576244354248,
            "end_logit": -3.515918493270874,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "potential transcribed ultraconserved region",
            "probability": 0.06249909186021897,
            "start_logit": -3.0820565223693848,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved region (T-UCR)",
            "probability": 0.06063354633162138,
            "start_logit": -1.6964576244354248,
            "end_logit": -3.729391098022461,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "potential transcribed ultraconserved region (T-UCR) biomarkers",
            "probability": 0.04841121878805897,
            "start_logit": -3.0820565223693848,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "screen potential transcribed ultraconserved region",
            "probability": 0.040872715326099596,
            "start_logit": -3.5067458152770996,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "trans",
            "probability": 0.032809193076943154,
            "start_logit": -1.6964576244354248,
            "end_logit": -4.343530654907227,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "screen potential transcribed ultraconserved region (T-UCR) biomarkers",
            "probability": 0.03165962744769594,
            "start_logit": -3.5067458152770996,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved region (T-UCR) bio",
            "probability": 0.02403869956421248,
            "start_logit": -1.6964576244354248,
            "end_logit": -4.654574394226074,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "biomarkers",
            "probability": 0.024019473106273625,
            "start_logit": -3.7829232215881348,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "transcribed ultraconserved",
            "probability": 0.022046868369253684,
            "start_logit": -1.6964576244354248,
            "end_logit": -4.7410688400268555,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "study attempted to screen potential transcribed ultraconserved region",
            "probability": 0.01986513433145324,
            "start_logit": -4.22824239730835,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "to screen potential transcribed ultraconserved region",
            "probability": 0.019320202041205523,
            "start_logit": -4.256057262420654,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "potential transcribed ultraconserved region (T-UCR) biomarkers related to LCXW.",
            "probability": 0.01877867685998863,
            "start_logit": -3.0820565223693848,
            "end_logit": -3.515918493270874,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "potential",
            "probability": 0.018281409471480877,
            "start_logit": -3.0820565223693848,
            "end_logit": -3.5427558422088623,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "study attempted to screen potential transcribed ultraconserved region (T-UCR) biomarkers",
            "probability": 0.015387349411812636,
            "start_logit": -4.22824239730835,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "potential transcribed ultraconserved region (T-UCR)",
            "probability": 0.01516893234940299,
            "start_logit": -3.0820565223693848,
            "end_logit": -3.729391098022461,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "to screen potential transcribed ultraconserved region (T-UCR) biomarkers",
            "probability": 0.014965249897361102,
            "start_logit": -4.256057262420654,
            "end_logit": -2.568908929824829,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        },
        {
            "text": "ultraconserved region",
            "probability": 0.012847311975562116,
            "start_logit": -4.664073944091797,
            "end_logit": -2.313488483428955,
            "question_text": "Which T-UCRs have been implicated in lung cancer?"
        }
    ],
    "5e3a6a4eb5b409ea53000016": [
        {
            "text": "facial weakness",
            "probability": 0.615844902671095,
            "start_logit": 1.1295243501663208,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia and left-sided facial weakness",
            "probability": 0.16049755452371509,
            "start_logit": -0.21519209444522858,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia",
            "probability": 0.06672536741928552,
            "start_logit": -0.21519209444522858,
            "end_logit": 0.4934658110141754,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal diplopia and left-sided facial weakness",
            "probability": 0.04770172899817354,
            "start_logit": -1.428503155708313,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left-sided facial weakness",
            "probability": 0.03155267678689876,
            "start_logit": -1.8418123722076416,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal diplopia",
            "probability": 0.019831550726014384,
            "start_logit": -1.428503155708313,
            "end_logit": 0.4934658110141754,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial weakness.",
            "probability": 0.015057711930908827,
            "start_logit": 1.1295243501663208,
            "end_logit": -2.3399455547332764,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial",
            "probability": 0.01335249788568199,
            "start_logit": 1.1295243501663208,
            "end_logit": -2.460132360458374,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "weakness",
            "probability": 0.011223258098844559,
            "start_logit": -2.8754825592041016,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia and left-sided facial weakness.",
            "probability": 0.003924244450431278,
            "start_logit": -0.21519209444522858,
            "end_logit": -2.3399455547332764,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "diplopia and left-sided facial",
            "probability": 0.0034798424865417343,
            "start_logit": -0.21519209444522858,
            "end_logit": -2.460132360458374,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial weakness. MRI revealed a T2 hyperintense lesion in his dorsal pons,",
            "probability": 0.001955296924985612,
            "start_logit": 1.1295243501663208,
            "end_logit": -4.381293773651123,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial nucleus lesion",
            "probability": 0.0016519883936373168,
            "start_logit": -1.1309243440628052,
            "end_logit": -2.28940749168396,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial weakness. MRI",
            "probability": 0.0014144746459110776,
            "start_logit": 1.1295243501663208,
            "end_logit": -4.705077648162842,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "ia and left-sided facial weakness",
            "probability": 0.00139419780599472,
            "start_logit": -4.961151599884033,
            "end_logit": 1.371159315109253,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal diplopia and left-sided facial weakness.",
            "probability": 0.0011663308257410215,
            "start_logit": -1.428503155708313,
            "end_logit": -2.3399455547332764,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "horizontal diplopia and left-sided facial",
            "probability": 0.0010342494235625055,
            "start_logit": -1.428503155708313,
            "end_logit": -2.460132360458374,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left-sided facial weakness.",
            "probability": 0.0007714785259170014,
            "start_logit": -1.8418123722076416,
            "end_logit": -2.3399455547332764,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "facial weakness. MRI revealed a T2 hyperintense lesion in his dorsal pons",
            "probability": 0.0007365352135607815,
            "start_logit": 1.1295243501663208,
            "end_logit": -5.3576340675354,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        },
        {
            "text": "left-sided facial",
            "probability": 0.0006841122630995955,
            "start_logit": -1.8418123722076416,
            "end_logit": -2.460132360458374,
            "question_text": "List symptoms of the One-and-a-half syndrome."
        }
    ],
    "5e475d3035b8f0833c000002": [
        {
            "text": "clinical factors",
            "probability": 0.17320256883510224,
            "start_logit": -1.5167227983474731,
            "end_logit": -1.4683146476745605,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors associated with successful short-stay appendectomy",
            "probability": 0.16004118600770778,
            "start_logit": -1.5167227983474731,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical",
            "probability": 0.12039271851334109,
            "start_logit": -1.5167227983474731,
            "end_logit": -1.832017421722412,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical factors",
            "probability": 0.09201852436463855,
            "start_logit": -2.1491947174072266,
            "end_logit": -1.4683146476745605,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical factors associated with successful short-stay appendectomy",
            "probability": 0.0850261856567297,
            "start_logit": -2.1491947174072266,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical",
            "probability": 0.0639618706371042,
            "start_logit": -2.1491947174072266,
            "end_logit": -1.832017421722412,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "short-stay appendectomy",
            "probability": 0.058588754727532916,
            "start_logit": -2.521611213684082,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "assess preoperative clinical factors",
            "probability": 0.032293500903769146,
            "start_logit": -3.1963186264038086,
            "end_logit": -1.4683146476745605,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "successful short-stay appendectomy",
            "probability": 0.0313578631830058,
            "start_logit": -3.146688938140869,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "assess preoperative clinical factors associated with successful short-stay appendectomy",
            "probability": 0.029839570046450502,
            "start_logit": -3.1963186264038086,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "factors",
            "probability": 0.028505995447593344,
            "start_logit": -3.3210701942443848,
            "end_logit": -1.4683146476745605,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "factors associated with successful short-stay appendectomy",
            "probability": 0.026339870998717943,
            "start_logit": -3.3210701942443848,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "assess preoperative clinical",
            "probability": 0.02244714030667345,
            "start_logit": -3.1963186264038086,
            "end_logit": -1.832017421722412,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors associated with successful short-stay appendectomy (SSA)",
            "probability": 0.017288661693176506,
            "start_logit": -1.5167227983474731,
            "end_logit": -3.7727255821228027,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors associated",
            "probability": 0.011717236558201647,
            "start_logit": -1.5167227983474731,
            "end_logit": -4.161715507507324,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "to assess preoperative clinical factors",
            "probability": 0.010177831508424686,
            "start_logit": -4.350972652435303,
            "end_logit": -1.4683146476745605,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "associated with successful short-stay appendectomy",
            "probability": 0.009409000778798651,
            "start_logit": -4.350487232208252,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "to assess preoperative clinical factors associated with successful short-stay appendectomy",
            "probability": 0.009404434567859525,
            "start_logit": -4.350972652435303,
            "end_logit": -1.5473452806472778,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "preoperative clinical factors associated with successful short-stay appendectomy (SSA)",
            "probability": 0.009185066641593246,
            "start_logit": -2.1491947174072266,
            "end_logit": -3.7727255821228027,
            "question_text": "Which factors are included in the the APPEND score?"
        },
        {
            "text": "clinical factors associated with successful short-stay appendectomy (SSA) and establish",
            "probability": 0.008802018623579034,
            "start_logit": -1.5167227983474731,
            "end_logit": -4.447795391082764,
            "question_text": "Which factors are included in the the APPEND score?"
        }
    ],
    "5e493a3e6d0a277941000002": [
        {
            "text": "NBL2 transcript (TNBL",
            "probability": 0.3055507810873053,
            "start_logit": 3.6791350841522217,
            "end_logit": 2.841022253036499,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "NBL2",
            "probability": 0.2757676234163004,
            "start_logit": 3.6791350841522217,
            "end_logit": 2.738464832305908,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL",
            "probability": 0.2325245527781488,
            "start_logit": 3.406014919281006,
            "end_logit": 2.841022253036499,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "NBL2 transcript (TNBL)",
            "probability": 0.07593437670766368,
            "start_logit": 3.6791350841522217,
            "end_logit": 1.4487757682800293,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL)",
            "probability": 0.05778616216134604,
            "start_logit": 3.406014919281006,
            "end_logit": 1.4487757682800293,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "(TNBL",
            "probability": 0.01235031298803115,
            "start_logit": 0.4707005023956299,
            "end_logit": 2.841022253036499,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "NBL2 transcript (TNBL),",
            "probability": 0.007791859537436,
            "start_logit": 3.6791350841522217,
            "end_logit": -0.8280141949653625,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Tumor-associated NBL2 transcript (TNBL",
            "probability": 0.0073495437739212474,
            "start_logit": -0.048342663794755936,
            "end_logit": 2.841022253036499,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Tumor-associated NBL2",
            "probability": 0.0066331567293530175,
            "start_logit": -0.048342663794755936,
            "end_logit": 2.738464832305908,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "TNBL),",
            "probability": 0.005929615521862378,
            "start_logit": 3.406014919281006,
            "end_logit": -0.8280141949653625,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "NBL2 transcript",
            "probability": 0.00566985578589499,
            "start_logit": 3.6791350841522217,
            "end_logit": -1.1459300518035889,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "(TNBL)",
            "probability": 0.003069255184206995,
            "start_logit": 0.4707005023956299,
            "end_logit": 1.4487757682800293,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Tumor-associated NBL2 transcript (TNBL)",
            "probability": 0.0018264820779461154,
            "start_logit": -0.048342663794755936,
            "end_logit": 1.4487757682800293,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "NBL",
            "probability": 0.0004213878748390043,
            "start_logit": 3.6791350841522217,
            "end_logit": -3.745295286178589,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "(TNBL),",
            "probability": 0.0003149456980724057,
            "start_logit": 0.4707005023956299,
            "end_logit": -0.8280141949653625,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "2 transcript (TNBL",
            "probability": 0.000284008824908303,
            "start_logit": -3.3017308712005615,
            "end_logit": 2.841022253036499,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "2",
            "probability": 0.0002563254408825757,
            "start_logit": -3.3017308712005615,
            "end_logit": 2.738464832305908,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "N",
            "probability": 0.00021595400892142255,
            "start_logit": 3.6791350841522217,
            "end_logit": -4.413783550262451,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Tumor-associated NBL2 transcript (TNBL),",
            "probability": 0.00018742093391758928,
            "start_logit": -0.048342663794755936,
            "end_logit": -0.8280141949653625,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        },
        {
            "text": "Tumor-associated NBL2 transcript",
            "probability": 0.00013637946904265718,
            "start_logit": -0.048342663794755936,
            "end_logit": -1.1459300518035889,
            "question_text": "Which lncRNAS are regulated by SAM68?"
        }
    ],
    "5e6e4a6c51b80c9423000002": [
        {
            "text": "Wdr5",
            "probability": 0.20512783151522773,
            "start_logit": 4.41662073135376,
            "end_logit": 3.7516355514526367,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5",
            "probability": 0.18629337901943913,
            "start_logit": 4.320310115814209,
            "end_logit": 3.7516355514526367,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx",
            "probability": 0.16765145099994724,
            "start_logit": 4.41662073135376,
            "end_logit": 3.549889326095581,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx",
            "probability": 0.15225800942556908,
            "start_logit": 4.320310115814209,
            "end_logit": 3.549889326095581,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx",
            "probability": 0.14853817786495555,
            "start_logit": 4.2955756187438965,
            "end_logit": 3.549889326095581,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2",
            "probability": 0.08713392021896257,
            "start_logit": 4.320310115814209,
            "end_logit": 2.9917590618133545,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57",
            "probability": 0.007354485112743448,
            "start_logit": 4.320310115814209,
            "end_logit": 0.5196231603622437,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins",
            "probability": 0.006784070669386904,
            "start_logit": 4.41662073135376,
            "end_logit": 0.34257951378822327,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx proteins",
            "probability": 0.006161170033199194,
            "start_logit": 4.320310115814209,
            "end_logit": 0.34257951378822327,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins",
            "probability": 0.006010645835317805,
            "start_logit": 4.2955756187438965,
            "end_logit": 0.34257951378822327,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5",
            "probability": 0.005857556522913319,
            "start_logit": 0.8607199192047119,
            "end_logit": 3.7516355514526367,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx",
            "probability": 0.004787394490189998,
            "start_logit": 0.8607199192047119,
            "end_logit": 3.549889326095581,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins,",
            "probability": 0.003295918153983732,
            "start_logit": 4.41662073135376,
            "end_logit": -0.37931302189826965,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter is accompanied by the simultaneous interaction of Wdr5 and Utx proteins,",
            "probability": 0.002993293135025222,
            "start_logit": 4.320310115814209,
            "end_logit": -0.37931302189826965,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins,",
            "probability": 0.0029201636732921906,
            "start_logit": 4.2955756187438965,
            "end_logit": -0.37931302189826965,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins, both are components of COMPASS complexes",
            "probability": 0.0018388959251554727,
            "start_logit": 4.41662073135376,
            "end_logit": -0.9628324508666992,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Utx proteins, both are components of COMPASS complexes",
            "probability": 0.001629250736433958,
            "start_logit": 4.2955756187438965,
            "end_logit": -0.9628324508666992,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 P1 promoter",
            "probability": 0.0014363386956912875,
            "start_logit": 4.320310115814209,
            "end_logit": -1.113589882850647,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Wdr5 and Utx proteins, both are components of COMPASS",
            "probability": 0.0010188468345582412,
            "start_logit": 4.41662073135376,
            "end_logit": -1.5533263683319092,
            "question_text": "List the components of the COMPASS complex"
        },
        {
            "text": "Runx2/p57 promoter, evidencing that the Mll2/COMPASS-\u00a0and",
            "probability": 0.000909201138008137,
            "start_logit": 1.7183759212493896,
            "end_logit": 1.0310580730438232,
            "question_text": "List the components of the COMPASS complex"
        }
    ],
    "5e6e5d1d51b80c9423000003": [
        {
            "text": "Schizophrenia",
            "probability": 0.888874490868922,
            "start_logit": 2.197824001312256,
            "end_logit": 2.2083165645599365,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia",
            "probability": 0.09452010662441272,
            "start_logit": 0.9955035448074341,
            "end_logit": 1.169493556022644,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "zophrenia",
            "probability": 0.0031734231333018334,
            "start_logit": -3.437321186065674,
            "end_logit": 2.2083165645599365,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia GWASs will facilitate the understanding of genetic mechanisms of schizophrenia",
            "probability": 0.0025322567390199295,
            "start_logit": -0.5386031270027161,
            "end_logit": -0.9161014556884766,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association studies",
            "probability": 0.0018955240149725265,
            "start_logit": 2.197824001312256,
            "end_logit": -3.9421441555023193,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia. However, the explained heritability is still low. Growing evidence has shown schizophrenia",
            "probability": 0.0017352443652231043,
            "start_logit": 0.9955035448074341,
            "end_logit": -2.8281707763671875,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "chizophrenia",
            "probability": 0.0014852287491804274,
            "start_logit": -4.196563243865967,
            "end_logit": 2.2083165645599365,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture.",
            "probability": 0.0008973895691439305,
            "start_logit": 2.197824001312256,
            "end_logit": -4.689904689788818,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0007385699378039117,
            "start_logit": -3.8563485145568848,
            "end_logit": 1.169493556022644,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "schizophrenia.",
            "probability": 0.0007193358436446044,
            "start_logit": 0.9955035448074341,
            "end_logit": -3.7087459564208984,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "S",
            "probability": 0.0006703226672174025,
            "start_logit": 2.197824001312256,
            "end_logit": -4.981635570526123,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association studies (GWAS)",
            "probability": 0.0005991018479535858,
            "start_logit": 2.197824001312256,
            "end_logit": -5.093963146209717,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome",
            "probability": 0.0005348885107526699,
            "start_logit": 2.197824001312256,
            "end_logit": -5.20733642578125,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.00048018567601515385,
            "start_logit": -4.286891460418701,
            "end_logit": 1.169493556022644,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder",
            "probability": 0.00045098887013166647,
            "start_logit": 2.197824001312256,
            "end_logit": -5.3779520988464355,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Schizophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association",
            "probability": 0.00035049284268527246,
            "start_logit": 2.197824001312256,
            "end_logit": -5.630054473876953,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "(GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.00017934930378514107,
            "start_logit": -5.271728992462158,
            "end_logit": 1.169493556022644,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "association studies (GWAS) have identified several significant loci associated with schizophrenia",
            "probability": 0.0001507123011456117,
            "start_logit": -5.4456915855407715,
            "end_logit": 1.169493556022644,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "zophrenia is a common psychiatric disorder with high heritability and complex genetic architecture. Genome-wide association studies",
            "probability": 6.7673218442377745e-06,
            "start_logit": -3.437321186065674,
            "end_logit": -3.9421441555023193,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        },
        {
            "text": "Genome-wide association studies (GWAS) have identified several significant loci associated with schizophrenia.",
            "probability": 5.620812843682303e-06,
            "start_logit": -3.8563485145568848,
            "end_logit": -3.7087459564208984,
            "question_text": "List psychiatric diseases that are associated with Synaptosome Associated Protein 25 (snap25)."
        }
    ],
    "5e44baaa48dab47f2600001a": [
        {
            "text": "PI3K/AKT",
            "probability": 0.14079103454589992,
            "start_logit": 5.532055377960205,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "AKT",
            "probability": 0.1191170046012971,
            "start_logit": 5.364884853363037,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK and PI3K/AKT",
            "probability": 0.09246188590034507,
            "start_logit": 5.111575126647949,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK and PI3K/AKT",
            "probability": 0.08545273466102869,
            "start_logit": 5.032742023468018,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK",
            "probability": 0.06526192558463882,
            "start_logit": 5.111575126647949,
            "end_logit": 4.862185001373291,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK",
            "probability": 0.06031469027640857,
            "start_logit": 5.032742023468018,
            "end_logit": 4.862185001373291,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK/MAPK and PI3K/AKT",
            "probability": 0.05277904402859002,
            "start_logit": 4.5508928298950195,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "PI3K",
            "probability": 0.04448895932801591,
            "start_logit": 5.532055377960205,
            "end_logit": 4.058537006378174,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK/MAPK and PI3K/AKT",
            "probability": 0.041707148201251876,
            "start_logit": 4.315451145172119,
            "end_logit": 5.210572719573975,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS",
            "probability": 0.039136472296284835,
            "start_logit": 5.032742023468018,
            "end_logit": 4.429664134979248,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK/MAPK",
            "probability": 0.037252777296091936,
            "start_logit": 4.5508928298950195,
            "end_logit": 4.862185001373291,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF",
            "probability": 0.033905537234666466,
            "start_logit": 5.032742023468018,
            "end_logit": 4.286187648773193,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK",
            "probability": 0.030419085723177083,
            "start_logit": 5.032742023468018,
            "end_logit": 4.177679538726807,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK/MAPK",
            "probability": 0.029437954631287094,
            "start_logit": 4.315451145172119,
            "end_logit": 4.862185001373291,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MAPK and PI3K",
            "probability": 0.0292172942295628,
            "start_logit": 5.111575126647949,
            "end_logit": 4.058537006378174,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAS/RAF/MEK/MAPK and PI3K",
            "probability": 0.027002452599798388,
            "start_logit": 5.032742023468018,
            "end_logit": 4.058537006378174,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF",
            "probability": 0.020941422759844976,
            "start_logit": 4.5508928298950195,
            "end_logit": 4.286187648773193,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK",
            "probability": 0.018788050154996534,
            "start_logit": 4.5508928298950195,
            "end_logit": 4.177679538726807,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "RAF/MEK/MAPK and PI3K",
            "probability": 0.016677800193264383,
            "start_logit": 4.5508928298950195,
            "end_logit": 4.058537006378174,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        },
        {
            "text": "MEK",
            "probability": 0.014846725753549556,
            "start_logit": 4.315451145172119,
            "end_logit": 4.177679538726807,
            "question_text": "Which kinases are inhibited by Pyrotinib?"
        }
    ],
    "5e35c75d158f994d3a000001": [
        {
            "text": "Treat to target",
            "probability": 0.16050314922847495,
            "start_logit": -5.522200107574463,
            "end_logit": -3.583609104156494,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat-to-target",
            "probability": 0.12880989244331517,
            "start_logit": -4.462444305419922,
            "end_logit": -4.863340854644775,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target",
            "probability": 0.08959585780872313,
            "start_logit": -4.562551975250244,
            "end_logit": -5.1262617111206055,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy in axSpA.",
            "probability": 0.07321616546823094,
            "start_logit": -4.562551975250244,
            "end_logit": -5.328154563903809,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy",
            "probability": 0.06520839374414947,
            "start_logit": -4.562551975250244,
            "end_logit": -5.4439826011657715,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat-to-target trials",
            "probability": 0.059844092894314124,
            "start_logit": -4.462444305419922,
            "end_logit": -5.6299357414245605,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "Treat-to-target trials and the research agenda for studies in axSpA are discussed.",
            "probability": 0.04677603422548135,
            "start_logit": -4.462444305419922,
            "end_logit": -5.876307487487793,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "discussed. Treat-to-target",
            "probability": 0.04624412922194527,
            "start_logit": -5.486847400665283,
            "end_logit": -4.863340854644775,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat-to-target strategy in axSpA. Potential targets of treatment, association of targets with outcomes, evidence of treatment impact on outcomes",
            "probability": 0.042189605890177236,
            "start_logit": -4.562551975250244,
            "end_logit": -5.879396915435791,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed. Treat-to-target",
            "probability": 0.03901152815803251,
            "start_logit": -5.656924724578857,
            "end_logit": -4.863340854644775,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "evidence of treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed. Treat-to-target",
            "probability": 0.031973528819738445,
            "start_logit": -5.8558735847473145,
            "end_logit": -4.863340854644775,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "discussed",
            "probability": 0.02802030280036389,
            "start_logit": -5.486847400665283,
            "end_logit": -5.364346027374268,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "discussed.",
            "probability": 0.02659903514054126,
            "start_logit": -5.486847400665283,
            "end_logit": -5.41640043258667,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "review focuses on background for a treat-to-target",
            "probability": 0.02598393468238975,
            "start_logit": -5.800382614135742,
            "end_logit": -5.1262617111206055,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "association of targets with outcomes, evidence of treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed",
            "probability": 0.02391793200758836,
            "start_logit": -5.645148277282715,
            "end_logit": -5.364346027374268,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed",
            "probability": 0.023637915776220358,
            "start_logit": -5.656924724578857,
            "end_logit": -5.364346027374268,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "association of targets with outcomes, evidence of treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed.",
            "probability": 0.02270474799974886,
            "start_logit": -5.645148277282715,
            "end_logit": -5.41640043258667,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treatment impact on outcomes, and how treat to target has been incorporated into treatment guidelines are discussed.",
            "probability": 0.02243893497013439,
            "start_logit": -5.656924724578857,
            "end_logit": -5.41640043258667,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "treat to target has been incorporated into treatment guidelines are discussed. Treat-to-target",
            "probability": 0.02184014923984214,
            "start_logit": -6.237031936645508,
            "end_logit": -4.863340854644775,
            "question_text": "List targeted genome editing methodologies"
        },
        {
            "text": "discussed. Treat-to-target trials",
            "probability": 0.02148466948058833,
            "start_logit": -5.486847400665283,
            "end_logit": -5.6299357414245605,
            "question_text": "List targeted genome editing methodologies"
        }
    ],
    "5e3e8b1c48dab47f26000008": [
        {
            "text": "promoted",
            "probability": 0.24560314226573018,
            "start_logit": 1.0116511583328247,
            "end_logit": -0.5008730292320251,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization",
            "probability": 0.22981073594578882,
            "start_logit": 1.0116511583328247,
            "end_logit": -0.5673339366912842,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "decreases",
            "probability": 0.12365806406930532,
            "start_logit": -0.06428807973861694,
            "end_logit": -0.11113057285547256,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "increases",
            "probability": 0.08671630839518724,
            "start_logit": -0.023918600752949715,
            "end_logit": -0.5063782930374146,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "decreases in p-\u03b1Syn monomers in TBS- and sarkosyl-soluble fractions and increases",
            "probability": 0.08328533544157456,
            "start_logit": -0.06428807973861694,
            "end_logit": -0.5063782930374146,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation",
            "probability": 0.04614841764956922,
            "start_logit": 1.0116511583328247,
            "end_logit": -2.172727346420288,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn",
            "probability": 0.027345911574448985,
            "start_logit": 1.0116511583328247,
            "end_logit": -2.6960229873657227,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn by activating GSK-3\u03b2",
            "probability": 0.02456242595243111,
            "start_logit": 1.0116511583328247,
            "end_logit": -2.8033721446990967,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2",
            "probability": 0.024285023713782605,
            "start_logit": 1.0002931356430054,
            "end_logit": -2.8033721446990967,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2 in rTg4510 mice",
            "probability": 0.02133813989779062,
            "start_logit": 1.0002931356430054,
            "end_logit": -2.9327359199523926,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn by activating",
            "probability": 0.014745616451739389,
            "start_logit": 1.0116511583328247,
            "end_logit": -3.3136441707611084,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating",
            "probability": 0.014579082941495467,
            "start_logit": 1.0002931356430054,
            "end_logit": -3.3136441707611084,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn by act",
            "probability": 0.01119863319993617,
            "start_logit": 1.0116511583328247,
            "end_logit": -3.5887982845306396,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "act",
            "probability": 0.01107215848096981,
            "start_logit": 1.0002931356430054,
            "end_logit": -3.5887982845306396,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "phosphorylation and dimerization",
            "probability": 0.010214207950383098,
            "start_logit": -2.10182523727417,
            "end_logit": -0.5673339366912842,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the phosphorylation and dimerization of endogenous \u03b1Syn by",
            "probability": 0.006563672622062595,
            "start_logit": 1.0116511583328247,
            "end_logit": -4.123039722442627,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "overexpression of human P301L mutant tau promoted",
            "probability": 0.005656980634550334,
            "start_logit": -2.7591755390167236,
            "end_logit": -0.5008730292320251,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "overexpression of human P301L mutant tau promoted the phosphorylation and dimerization",
            "probability": 0.00529323391738415,
            "start_logit": -2.7591755390167236,
            "end_logit": -0.5673339366912842,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "activating GSK-3\u03b2 in rTg4510 mice.",
            "probability": 0.004578815099444636,
            "start_logit": 1.0002931356430054,
            "end_logit": -4.471791744232178,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        },
        {
            "text": "promoted the p",
            "probability": 0.0033440937964257225,
            "start_logit": 1.0116511583328247,
            "end_logit": -4.797394275665283,
            "question_text": "What are the effects of 14-3-3 dimers on Tau phosphorylation?"
        }
    ],
    "5e47546d3f54159529000019": [
        {
            "text": "ulcerative colitis",
            "probability": 0.7702642656051552,
            "start_logit": 4.654204845428467,
            "end_logit": 4.748693943023682,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis",
            "probability": 0.22391413396323742,
            "start_logit": 3.418733835220337,
            "end_logit": 4.748693943023682,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative",
            "probability": 0.001897517282525366,
            "start_logit": 4.654204845428467,
            "end_logit": -1.2574933767318726,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis in the macaque. Furthermore, signs of colitis",
            "probability": 0.0011762031053817537,
            "start_logit": 1.4828437566757202,
            "end_logit": 1.4356129169464111,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ulcerative co",
            "probability": 0.0006231327989854782,
            "start_logit": 4.654204845428467,
            "end_logit": -2.37103533744812,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "is",
            "probability": 0.000621922565030004,
            "start_logit": -2.467468500137329,
            "end_logit": 4.748693943023682,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Following subsequent DSS treatments, mild to moderate colitis",
            "probability": 0.0002660198202118443,
            "start_logit": 0.6935501098632812,
            "end_logit": 0.7384305596351624,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Following subsequent DSS treatments, mild to moderate colitis emerged with each DSS treatment and reduced signs of colitis",
            "probability": 0.0002209653326262433,
            "start_logit": 0.6935501098632812,
            "end_logit": 0.5528655648231506,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "ul",
            "probability": 0.0002091412766510367,
            "start_logit": 4.654204845428467,
            "end_logit": -3.462785005569458,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis emerged with each DSS treatment and reduced signs of colitis",
            "probability": 0.00019307326513798447,
            "start_logit": 0.5586140155792236,
            "end_logit": 0.5528655648231506,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "co",
            "probability": 0.00018114333905818884,
            "start_logit": 3.418733835220337,
            "end_logit": -2.37103533744812,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "litis",
            "probability": 0.00012435636930575877,
            "start_logit": -4.077132701873779,
            "end_logit": 4.748693943023682,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis during DSS treatment and further reduced signs of colitis",
            "probability": 7.87394794498632e-05,
            "start_logit": 0.12542875111103058,
            "end_logit": 0.08912577480077744,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "induced ulcerative colitis",
            "probability": 7.379350820632817e-05,
            "start_logit": -4.599013328552246,
            "end_logit": 4.748693943023682,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis were observed 2 weeks after DSS treatment termination. Prednisolone treatment during DSS treatment suppressed the emergence of colitis",
            "probability": 5.104586667768584e-05,
            "start_logit": 0.20667073130607605,
            "end_logit": -0.42553630471229553,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Vedolizumab reduced signs of colitis during DSS treatment and further reduced signs of colitis",
            "probability": 4.346485934868495e-05,
            "start_logit": -0.468763142824173,
            "end_logit": 0.08912577480077744,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis. Vedolizumab reduced signs of colitis",
            "probability": 3.507713945272371e-05,
            "start_logit": -0.468763142824173,
            "end_logit": -0.12527738511562347,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis is that disease and treatment assessment methods differ from clinically used methods. Thus, a modified Mayo score",
            "probability": 2.292169161039632e-05,
            "start_logit": 3.722578525543213,
            "end_logit": -4.742084980010986,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "is in the macaque. Furthermore, signs of colitis",
            "probability": 2.124516761807506e-06,
            "start_logit": -4.833658695220947,
            "end_logit": 1.4356129169464111,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        },
        {
            "text": "colitis that persisted after termination of DSS treatment. The current study demonstrated the potential of utilizing clinical outcome measures to assess experimentally-induced co",
            "probability": 9.58215186167723e-07,
            "start_logit": 0.147516667842865,
            "end_logit": -4.341789722442627,
            "question_text": "Rachmilewitz Index is used for which diseases?"
        }
    ],
    "5e80669e835f4e4777000025": [
        {
            "text": "angiotensin-converting enzyme 2",
            "probability": 0.11379479858645705,
            "start_logit": -4.806585311889648,
            "end_logit": -5.063455581665039,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin II receptor blockers",
            "probability": 0.09247490997927707,
            "start_logit": -4.906911373138428,
            "end_logit": -5.170588970184326,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers",
            "probability": 0.08720748884664584,
            "start_logit": -4.9655585289001465,
            "end_logit": -5.170588970184326,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme inhibitors",
            "probability": 0.06088220658379919,
            "start_logit": -4.9655585289001465,
            "end_logit": -5.529938220977783,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "cardiovascular disease, and chronic kidney disease",
            "probability": 0.05955280495899298,
            "start_logit": -5.031734943389893,
            "end_logit": -5.485839366912842,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "chronic kidney disease",
            "probability": 0.05668576659614583,
            "start_logit": -5.081075191497803,
            "end_logit": -5.485839366912842,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin II receptor blockers. Coronavirus binding to angiotensin-converting enzyme 2",
            "probability": 0.054190980860299144,
            "start_logit": -5.548467636108398,
            "end_logit": -5.063455581665039,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "cardiovascular disease",
            "probability": 0.0524437159961862,
            "start_logit": -5.031734943389893,
            "end_logit": -5.612962245941162,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme 2,",
            "probability": 0.05168871211956108,
            "start_logit": -4.806585311889648,
            "end_logit": -5.8526129722595215,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "hypertension",
            "probability": 0.04716406791177849,
            "start_logit": -5.402520656585693,
            "end_logit": -5.348284721374512,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "cardiovascular disease, and chronic kidney disease, as well as the medications commonly prescribed for these conditions, angiotensin-converting enzyme inhibitors",
            "probability": 0.0451310800574108,
            "start_logit": -5.031734943389893,
            "end_logit": -5.763131618499756,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "chronic kidney disease, as well as the medications commonly prescribed for these conditions, angiotensin-converting enzyme inhibitors",
            "probability": 0.04295834381147881,
            "start_logit": -5.081075191497803,
            "end_logit": -5.763131618499756,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "hypertension, cardiovascular disease, and chronic kidney disease",
            "probability": 0.04110285912147962,
            "start_logit": -5.402520656585693,
            "end_logit": -5.485839366912842,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "hypertension, cardiovascular disease",
            "probability": 0.036196224038186404,
            "start_logit": -5.402520656585693,
            "end_logit": -5.612962245941162,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme",
            "probability": 0.031127365219810733,
            "start_logit": -4.806585311889648,
            "end_logit": -6.35976505279541,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-converting enzyme 2, a crucial component of the renin-angiotensin-aldosterone system,",
            "probability": 0.02910453007515481,
            "start_logit": -4.806585311889648,
            "end_logit": -6.4269585609436035,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin-(1-7) pathway in children and the clinical evidence for how angiotensin-converting enzyme inhibitors",
            "probability": 0.026163967961097594,
            "start_logit": -5.810116291046143,
            "end_logit": -5.529938220977783,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin II receptor blockers. Coronavirus binding to angiotensin-converting enzyme 2,",
            "probability": 0.02461502673196881,
            "start_logit": -5.548467636108398,
            "end_logit": -5.8526129722595215,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "angiotensin II receptor blockers affect this important pathway. Given the importance of the angiotensin-converting enzyme 2",
            "probability": 0.02423727747876392,
            "start_logit": -4.906911373138428,
            "end_logit": -6.509634494781494,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        },
        {
            "text": "hypertension, use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers",
            "probability": 0.023277873065505814,
            "start_logit": -5.581625461578369,
            "end_logit": -5.875308990478516,
            "question_text": "List angiotensin-converting-enzyme inhibitors."
        }
    ],
    "5d387360a1e1595105000007": [
        {
            "text": "apoptosis",
            "probability": 0.20433830635439731,
            "start_logit": 5.283161640167236,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "promote apoptosis",
            "probability": 0.20149616925679525,
            "start_logit": 5.269155025482178,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.12377125756447305,
            "start_logit": 4.781819820404053,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration and invasion",
            "probability": 0.06505883328412654,
            "start_logit": 4.781819820404053,
            "end_logit": 5.453286647796631,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration and invasion, and promote apoptosis",
            "probability": 0.06440566769074715,
            "start_logit": 4.128586292266846,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.05377578106937852,
            "start_logit": 3.9482078552246094,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "invasion, and promote apoptosis",
            "probability": 0.04181295605660987,
            "start_logit": 3.6965909004211426,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation, migration and invasion, and promote apoptosis",
            "probability": 0.03441646525463165,
            "start_logit": 3.501919746398926,
            "end_logit": 6.096429824829102,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration and invasion",
            "probability": 0.0338540439783647,
            "start_logit": 4.128586292266846,
            "end_logit": 5.453286647796631,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation",
            "probability": 0.030673641809150345,
            "start_logit": 4.781819820404053,
            "end_logit": 4.7013983726501465,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration and invasion",
            "probability": 0.028266575327425703,
            "start_logit": 3.9482078552246094,
            "end_logit": 5.453286647796631,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "proliferation, migration",
            "probability": 0.022221512255451825,
            "start_logit": 4.781819820404053,
            "end_logit": 4.379055500030518,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "invasion",
            "probability": 0.021978464069385997,
            "start_logit": 3.6965909004211426,
            "end_logit": 5.453286647796631,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation, migration and invasion",
            "probability": 0.01809059000684112,
            "start_logit": 3.501919746398926,
            "end_logit": 5.453286647796631,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation",
            "probability": 0.013326995935790448,
            "start_logit": 3.9482078552246094,
            "end_logit": 4.7013983726501465,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "migration",
            "probability": 0.011563196190076532,
            "start_logit": 4.128586292266846,
            "end_logit": 4.379055500030518,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "inhibit liver cells proliferation, migration",
            "probability": 0.009654738923996297,
            "start_logit": 3.9482078552246094,
            "end_logit": 4.379055500030518,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "liver cells proliferation",
            "probability": 0.00852926881677462,
            "start_logit": 3.501919746398926,
            "end_logit": 4.7013983726501465,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "apoptosis. CAMK4 might exert an antitumor",
            "probability": 0.006427467833552767,
            "start_logit": 5.283161640167236,
            "end_logit": 2.6372334957122803,
            "question_text": "What are the effects of CAMK4 inhibition?"
        },
        {
            "text": "promote apoptosis. CAMK4 might exert an antitumor",
            "probability": 0.006338068322030432,
            "start_logit": 5.269155025482178,
            "end_logit": 2.6372334957122803,
            "question_text": "What are the effects of CAMK4 inhibition?"
        }
    ],
    "5e4949d36d0a277941000006": [
        {
            "text": "ciliopathies",
            "probability": 0.5341529280374449,
            "start_logit": 0.5071947574615479,
            "end_logit": -0.2579823136329651,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies",
            "probability": 0.1326357506678711,
            "start_logit": -0.8858807682991028,
            "end_logit": -0.2579823136329651,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies",
            "probability": 0.11188762595282699,
            "start_logit": -0.8858807682991028,
            "end_logit": -0.42809394001960754,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.0694638348639619,
            "start_logit": 0.5071947574615479,
            "end_logit": -2.297858238220215,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies",
            "probability": 0.03619086655526412,
            "start_logit": 0.5071947574615479,
            "end_logit": -2.949857711791992,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies",
            "probability": 0.022057008715858892,
            "start_logit": -2.679857015609741,
            "end_logit": -0.2579823136329651,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies",
            "probability": 0.02141275201160092,
            "start_logit": -0.8858807682991028,
            "end_logit": -2.0816023349761963,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.017248595669599607,
            "start_logit": -0.8858807682991028,
            "end_logit": -2.297858238220215,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies, linkeropathies",
            "probability": 0.016240980807841844,
            "start_logit": 0.5071947574615479,
            "end_logit": -3.751126766204834,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies, linkeropathies, lysosomal storage diseases",
            "probability": 0.010398520259762449,
            "start_logit": 0.5071947574615479,
            "end_logit": -4.197000980377197,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "aggrecanopathies, channelopathies, ciliopathies, cohesinopathies",
            "probability": 0.008986570139219954,
            "start_logit": -0.8858807682991028,
            "end_logit": -2.949857711791992,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies",
            "probability": 0.0035608895442758937,
            "start_logit": -2.679857015609741,
            "end_logit": -2.0816023349761963,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies, cohesinopathies, laminopathies",
            "probability": 0.0028684002850284554,
            "start_logit": -2.679857015609741,
            "end_logit": -2.297858238220215,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies,",
            "probability": 0.0027929991274352863,
            "start_logit": 0.5071947574615479,
            "end_logit": -5.5115485191345215,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies,",
            "probability": 0.0025691106779663713,
            "start_logit": 0.5071947574615479,
            "end_logit": -5.595104694366455,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopath",
            "probability": 0.0018165268704934314,
            "start_logit": 0.5071947574615479,
            "end_logit": -5.941738128662109,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ciliopathies, cohesinopathies, laminopathies, linkeropathies, lysosomal storage diseases,",
            "probability": 0.0016993582877913944,
            "start_logit": 0.5071947574615479,
            "end_logit": -6.008413791656494,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "channelopathies, ciliopathies, cohesinopathies",
            "probability": 0.0014944451619443105,
            "start_logit": -2.679857015609741,
            "end_logit": -2.949857711791992,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ggrecanopathies, channelopathies, ciliopathies",
            "probability": 0.0013684511458611993,
            "start_logit": -5.459807872772217,
            "end_logit": -0.2579823136329651,
            "question_text": "List cohesinopathies"
        },
        {
            "text": "ggrecanopathies",
            "probability": 0.001154385217951079,
            "start_logit": -5.459807872772217,
            "end_logit": -0.42809394001960754,
            "question_text": "List cohesinopathies"
        }
    ],
    "5e3c841148dab47f26000002": [
        {
            "text": "Alzheimer's disease",
            "probability": 0.8335335202469509,
            "start_logit": 5.436099529266357,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease. Alzheimer's disease",
            "probability": 0.11053015878126737,
            "start_logit": 5.436099529266357,
            "end_logit": 3.1446425914764404,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease.",
            "probability": 0.022615546442622186,
            "start_logit": 5.436099529266357,
            "end_logit": 1.5579917430877686,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's",
            "probability": 0.022252716332858635,
            "start_logit": 5.436099529266357,
            "end_logit": 1.5418182611465454,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease, and the acetylation of the K274 residue is thought to be linked with dementia",
            "probability": 0.0060837919902964116,
            "start_logit": 4.139663219451904,
            "end_logit": 1.5414186716079712,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease. Alzheimer's",
            "probability": 0.0017347362800208994,
            "start_logit": 5.436099529266357,
            "end_logit": -1.0097904205322266,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "dementia",
            "probability": 0.0013773110635615824,
            "start_logit": 2.654168128967285,
            "end_logit": 1.5414186716079712,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease,",
            "probability": 0.0010495039092019082,
            "start_logit": 4.139663219451904,
            "end_logit": -0.21589192748069763,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease",
            "probability": 0.00019444435688369078,
            "start_logit": -2.9271836280822754,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer",
            "probability": 0.00017995678607080586,
            "start_logit": 5.436099529266357,
            "end_logit": -3.275684356689453,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Al",
            "probability": 0.00011139455034509079,
            "start_logit": 5.436099529266357,
            "end_logit": -3.7553226947784424,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease",
            "probability": 0.00010520244672114774,
            "start_logit": -3.541443109512329,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "microtubule-associated protein, is known to play an important role in several neurological disorders including Alzheimer's disease",
            "probability": 7.312467802003116e-05,
            "start_logit": -3.9051637649536133,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "Alzheimer's disease. Al",
            "probability": 3.4332369035284315e-05,
            "start_logit": 5.436099529266357,
            "end_logit": -4.932312488555908,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "several neurological disorders including Alzheimer's disease",
            "probability": 3.0248652282872656e-05,
            "start_logit": -4.787878036499023,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disease. Alzheimer's disease",
            "probability": 2.578416478572852e-05,
            "start_logit": -2.9271836280822754,
            "end_logit": 3.1446425914764404,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "a microtubule-associated protein, is known to play an important role in several neurological disorders including Alzheimer's disease",
            "probability": 2.408370305954229e-05,
            "start_logit": -5.015794277191162,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "disorders including Alzheimer's disease",
            "probability": 1.7078464637875648e-05,
            "start_logit": -5.359511375427246,
            "end_logit": 5.165028095245361,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": "heimer's disease. Alzheimer's disease",
            "probability": 1.3950300567182041e-05,
            "start_logit": -3.541443109512329,
            "end_logit": 3.1446425914764404,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        },
        {
            "text": ". Alzheimer's disease",
            "probability": 1.3114480810299823e-05,
            "start_logit": -3.603227138519287,
            "end_logit": 3.1446425914764404,
            "question_text": "Before 2019, what neurologic diseases are associated with the tau protein?"
        }
    ],
    "5e4703d13f54159529000016": [
        {
            "text": "chitosan-based long-circulating nanocarriers",
            "probability": 0.5606272628651552,
            "start_logit": 2.089268684387207,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "nanocarriers",
            "probability": 0.12725947709829707,
            "start_logit": 0.606440544128418,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan",
            "probability": 0.12230342296816352,
            "start_logit": 2.089268684387207,
            "end_logit": -0.16915208101272583,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "long-circulating nanocarriers",
            "probability": 0.04148054659958784,
            "start_logit": -0.5145630240440369,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based",
            "probability": 0.03315181435738688,
            "start_logit": 2.089268684387207,
            "end_logit": -1.4745596647262573,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers with radio-protective agents",
            "probability": 0.024979184465216308,
            "start_logit": 2.089268684387207,
            "end_logit": -1.757614254951477,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarrier",
            "probability": 0.02174811368430222,
            "start_logit": 2.089268684387207,
            "end_logit": -1.896130084991455,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers with radio-protective agents.",
            "probability": 0.011836042574092528,
            "start_logit": 2.089268684387207,
            "end_logit": -2.5045077800750732,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "based long-circulating nanocarriers",
            "probability": 0.011656392939582844,
            "start_logit": -1.7839328050613403,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "nanocarriers with radio-protective agents",
            "probability": 0.005670145146241172,
            "start_logit": 0.606440544128418,
            "end_logit": -1.757614254951477,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.005129321010233589,
            "start_logit": -2.604814291000366,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "nanocarrier",
            "probability": 0.004936708859276986,
            "start_logit": 0.606440544128418,
            "end_logit": -1.896130084991455,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "by chitosan-based long-circulating nanocarriers",
            "probability": 0.004863610946181962,
            "start_logit": -2.658006429672241,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "We demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.00405882666379963,
            "start_logit": -2.8388936519622803,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "demonstrate a strategy for effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.0037842898108638983,
            "start_logit": -2.9089293479919434,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "riers",
            "probability": 0.0034217419109674923,
            "start_logit": -3.0096378326416016,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "effective radioprotection by chitosan-based long-circulating nanocarriers",
            "probability": 0.0033987873926148177,
            "start_logit": -3.016368865966797,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "san-based long-circulating nanocarriers",
            "probability": 0.0033407349599452302,
            "start_logit": -3.0335967540740967,
            "end_logit": 1.3533991575241089,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "ch",
            "probability": 0.003178468934843068,
            "start_logit": 2.089268684387207,
            "end_logit": -3.8192574977874756,
            "question_text": "List radioprotection agents."
        },
        {
            "text": "chitosan-based long-circulating nanocarriers with radio-protective agents. The stable encapsulation",
            "probability": 0.003175106813247536,
            "start_logit": 2.089268684387207,
            "end_logit": -3.8203158378601074,
            "question_text": "List radioprotection agents."
        }
    ],
    "5e52c5166d0a27794100004d": [
        {
            "text": "early stages",
            "probability": 0.7429961084924726,
            "start_logit": 1.9431818723678589,
            "end_logit": 2.0147273540496826,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early",
            "probability": 0.15208103911839504,
            "start_logit": 1.9431818723678589,
            "end_logit": 0.4284500777721405,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "stages",
            "probability": 0.044805421943845056,
            "start_logit": -0.8651797771453857,
            "end_logit": 2.0147273540496826,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis",
            "probability": 0.032127047767002315,
            "start_logit": 1.9431818723678589,
            "end_logit": -1.1262651681900024,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems",
            "probability": 0.005161567608012619,
            "start_logit": 1.9431818723678589,
            "end_logit": -2.9547231197357178,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait stability",
            "probability": 0.004243788904766161,
            "start_logit": 1.9431818723678589,
            "end_logit": -3.1505069732666016,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait stability.",
            "probability": 0.003714417907977433,
            "start_logit": 1.9431818723678589,
            "end_logit": -3.2837414741516113,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "at early stages",
            "probability": 0.00362944159795051,
            "start_logit": -3.378430128097534,
            "end_logit": 2.0147273540496826,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance",
            "probability": 0.0033631649962427273,
            "start_logit": 1.9431818723678589,
            "end_logit": -3.3830809593200684,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "stages of multiple sclerosis",
            "probability": 0.0019373801754241455,
            "start_logit": -0.8651797771453857,
            "end_logit": -1.1262651681900024,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that",
            "probability": 0.0011843054994532978,
            "start_logit": 1.9431818723678589,
            "end_logit": -4.426806926727295,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple",
            "probability": 0.0009689393169807423,
            "start_logit": 1.9431818723678589,
            "end_logit": -4.627516746520996,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "at early",
            "probability": 0.000742896555347751,
            "start_logit": -3.378430128097534,
            "end_logit": 0.4284500777721405,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "People at early stages",
            "probability": 0.0006031282657676643,
            "start_logit": -5.1731343269348145,
            "end_logit": 2.0147273540496826,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait",
            "probability": 0.0004936957490037455,
            "start_logit": 1.9431818723678589,
            "end_logit": -5.301799297332764,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "multiple sclerosis",
            "probability": 0.0004621497313582952,
            "start_logit": -2.2983827590942383,
            "end_logit": -1.1262651681900024,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle",
            "probability": 0.0004512509926815076,
            "start_logit": 1.9431818723678589,
            "end_logit": -5.391695022583008,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have subtle balance problems that may affect gait stability. However, differences in methods of determining stability such as sensor type",
            "probability": 0.0004118590834178967,
            "start_logit": 1.9431818723678589,
            "end_logit": -5.48303747177124,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "stages of multiple sclerosis have subtle balance problems",
            "probability": 0.00031126167677772085,
            "start_logit": -0.8651797771453857,
            "end_logit": -2.9547231197357178,
            "question_text": "List the stages/types of Multiple Sclerosis."
        },
        {
            "text": "early stages of multiple sclerosis have",
            "probability": 0.0003111346171227105,
            "start_logit": 1.9431818723678589,
            "end_logit": -5.763493061065674,
            "question_text": "List the stages/types of Multiple Sclerosis."
        }
    ],
    "5e6e8897c6a8763d23000003": [
        {
            "text": "AZD5991, S64315",
            "probability": 0.23211686266261713,
            "start_logit": 3.9678776264190674,
            "end_logit": 4.520552158355713,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176, and AMG 397",
            "probability": 0.15715431522281928,
            "start_logit": 4.475627422332764,
            "end_logit": 3.6227896213531494,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 397",
            "probability": 0.14625590993850326,
            "start_logit": 4.403757095336914,
            "end_logit": 3.6227896213531494,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991",
            "probability": 0.13741240247277184,
            "start_logit": 3.9678776264190674,
            "end_logit": 3.996297836303711,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176, and AMG 397",
            "probability": 0.09458306340102698,
            "start_logit": 3.9678776264190674,
            "end_logit": 3.6227896213531494,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176",
            "probability": 0.0812837414701927,
            "start_logit": 4.475627422332764,
            "end_logit": 2.9635074138641357,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176",
            "probability": 0.048920484697143024,
            "start_logit": 3.9678776264190674,
            "end_logit": 2.9635074138641357,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315",
            "probability": 0.04136005025160683,
            "start_logit": 2.2429521083831787,
            "end_logit": 4.520552158355713,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "venetoclax",
            "probability": 0.029586051266580253,
            "start_logit": 3.185662269592285,
            "end_logit": 3.2428295612335205,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315, AMG 176, and AMG 397",
            "probability": 0.0168534082803947,
            "start_logit": 2.2429521083831787,
            "end_logit": 3.6227896213531494,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315, AMG 176",
            "probability": 0.008716961284918587,
            "start_logit": 2.2429521083831787,
            "end_logit": 2.9635074138641357,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315,",
            "probability": 0.0019304045273872133,
            "start_logit": 3.9678776264190674,
            "end_logit": -0.2689592242240906,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991,",
            "probability": 0.001157580142362687,
            "start_logit": 3.9678776264190674,
            "end_logit": -0.7803570628166199,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG 176,",
            "probability": 0.000612319671846584,
            "start_logit": 4.475627422332764,
            "end_logit": -1.9249393939971924,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AMG",
            "probability": 0.00046967646985714953,
            "start_logit": 4.475627422332764,
            "end_logit": -2.1901497840881348,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "176, and AMG 397",
            "probability": 0.000389922369148019,
            "start_logit": -1.5234084129333496,
            "end_logit": 3.6227896213531494,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG 176,",
            "probability": 0.0003685235767267818,
            "start_logit": 3.9678776264190674,
            "end_logit": -1.9249393939971924,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "S64315,",
            "probability": 0.0003439716845333836,
            "start_logit": 2.2429521083831787,
            "end_logit": -0.2689592242240906,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "AZD5991, S64315, AMG",
            "probability": 0.0002826740027054561,
            "start_logit": 3.9678776264190674,
            "end_logit": -2.1901497840881348,
            "question_text": "List Mcl-1 inhibitors."
        },
        {
            "text": "176",
            "probability": 0.00020167660685826654,
            "start_logit": -1.5234084129333496,
            "end_logit": 2.9635074138641357,
            "question_text": "List Mcl-1 inhibitors."
        }
    ],
    "5e7659db835f4e4777000001": [
        {
            "text": "oral poliovirus vaccine",
            "probability": 0.3505928007252402,
            "start_logit": 5.318838596343994,
            "end_logit": 5.413240909576416,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus",
            "probability": 0.34359636953652145,
            "start_logit": 5.318838596343994,
            "end_logit": 5.393083095550537,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "poliovirus vaccine",
            "probability": 0.14461788184919472,
            "start_logit": 4.433308124542236,
            "end_logit": 5.413240909576416,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "poliovirus",
            "probability": 0.14173188688032168,
            "start_logit": 4.433308124542236,
            "end_logit": 5.393083095550537,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus vaccine (OPV)",
            "probability": 0.008426481827353808,
            "start_logit": 5.318838596343994,
            "end_logit": 1.6849948167800903,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "poliovirus vaccine (OPV)",
            "probability": 0.003475884133364372,
            "start_logit": 4.433308124542236,
            "end_logit": 1.6849948167800903,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus vaccine (OPV",
            "probability": 0.001868431280434176,
            "start_logit": 5.318838596343994,
            "end_logit": 0.17871466279029846,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral polio",
            "probability": 0.0015056236878321994,
            "start_logit": 5.318838596343994,
            "end_logit": -0.03717730566859245,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus vaccine (OPV),",
            "probability": 0.0009735672803803745,
            "start_logit": 5.318838596343994,
            "end_logit": -0.4731728732585907,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "poliovirus vaccine (OPV",
            "probability": 0.0007707191180144395,
            "start_logit": 4.433308124542236,
            "end_logit": 0.17871466279029846,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "polio",
            "probability": 0.00062106269194874,
            "start_logit": 4.433308124542236,
            "end_logit": -0.03717730566859245,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "poliovirus vaccine (OPV),",
            "probability": 0.0004015919255473592,
            "start_logit": 4.433308124542236,
            "end_logit": -0.4731728732585907,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral",
            "probability": 0.000286298643110611,
            "start_logit": 5.318838596343994,
            "end_logit": -1.6971043348312378,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "virus vaccine",
            "probability": 0.00022656779309420834,
            "start_logit": -2.0254979133605957,
            "end_logit": 5.413240909576416,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "virus",
            "probability": 0.00022204640540260598,
            "start_logit": -2.0254979133605957,
            "end_logit": 5.393083095550537,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oliovirus vaccine",
            "probability": 0.00017243553613732027,
            "start_logit": -2.298518657684326,
            "end_logit": 5.413240909576416,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oliovirus",
            "probability": 0.00016899441195970184,
            "start_logit": -2.298518657684326,
            "end_logit": 5.393083095550537,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "vaccine",
            "probability": 0.00012836588042521014,
            "start_logit": -2.5936574935913086,
            "end_logit": 5.413240909576416,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus vaccine (OPV), when administered concomitantly with rotavirus vaccine",
            "probability": 0.00010841058423779531,
            "start_logit": 5.318838596343994,
            "end_logit": -2.6682140827178955,
            "question_text": "Name two rotavirus vaccines."
        },
        {
            "text": "oral poliovirus vaccine (OPV), when administered concomitantly with rotavirus vaccine,",
            "probability": 0.00010457980947945489,
            "start_logit": 5.318838596343994,
            "end_logit": -2.7041893005371094,
            "question_text": "Name two rotavirus vaccines."
        }
    ],
    "5e80e449835f4e477700002c": [
        {
            "text": "gallbladder",
            "probability": 0.18625805674015375,
            "start_logit": 5.217869758605957,
            "end_logit": 4.872725963592529,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "gallbladder, and testis",
            "probability": 0.15945115007247457,
            "start_logit": 5.217869758605957,
            "end_logit": 4.717330455780029,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder",
            "probability": 0.12070126256259299,
            "start_logit": 4.784055233001709,
            "end_logit": 4.872725963592529,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "testis",
            "probability": 0.10565499039339059,
            "start_logit": 4.806311130523682,
            "end_logit": 4.717330455780029,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder, and testis",
            "probability": 0.10332951748581251,
            "start_logit": 4.784055233001709,
            "end_logit": 4.717330455780029,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine",
            "probability": 0.08354108819571286,
            "start_logit": 4.784055233001709,
            "end_logit": 4.504745960235596,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, gallbladder",
            "probability": 0.05614251581443596,
            "start_logit": 4.018630027770996,
            "end_logit": 4.872725963592529,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney, gallbladder, and testis",
            "probability": 0.04806228987486277,
            "start_logit": 4.018630027770996,
            "end_logit": 4.717330455780029,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney",
            "probability": 0.033728431379284066,
            "start_logit": 4.784055233001709,
            "end_logit": 3.5977485179901123,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "placenta and ovary",
            "probability": 0.025282275347584388,
            "start_logit": 4.1656494140625,
            "end_logit": 3.9279167652130127,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "ovary",
            "probability": 0.022330464435753265,
            "start_logit": 4.041497707366943,
            "end_logit": 3.9279167652130127,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "kidney",
            "probability": 0.015688311388835686,
            "start_logit": 4.018630027770996,
            "end_logit": 3.5977485179901123,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "placenta",
            "probability": 0.014541037896878932,
            "start_logit": 4.1656494140625,
            "end_logit": 3.3747880458831787,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine, kidney, gallbladder",
            "probability": 0.005166102482240932,
            "start_logit": 1.6328551769256592,
            "end_logit": 4.872725963592529,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "gallbladder, and testis,",
            "probability": 0.0044593161912765515,
            "start_logit": 5.217869758605957,
            "end_logit": 1.1405882835388184,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine, kidney, gallbladder, and testis",
            "probability": 0.004422579063706075,
            "start_logit": 1.6328551769256592,
            "end_logit": 4.717330455780029,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "the small intestine",
            "probability": 0.0035756197900015507,
            "start_logit": 1.6328551769256592,
            "end_logit": 4.504745960235596,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "testis,",
            "probability": 0.0029548172536621145,
            "start_logit": 4.806311130523682,
            "end_logit": 1.1405882835388184,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "small intestine, kidney, gallbladder, and testis,",
            "probability": 0.002889781542195472,
            "start_logit": 4.784055233001709,
            "end_logit": 1.1405882835388184,
            "question_text": "Which tissues express the ACE2 protein?"
        },
        {
            "text": "intestine, kidney, gallbladder",
            "probability": 0.0018203920891449019,
            "start_logit": 0.589788556098938,
            "end_logit": 4.872725963592529,
            "question_text": "Which tissues express the ACE2 protein?"
        }
    ],
    "5e7768f9835f4e477700000b": [
        {
            "text": "Afrezza",
            "probability": 0.9899514295695998,
            "start_logit": 3.066305637359619,
            "end_logit": 2.90075421333313,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation insulin",
            "probability": 0.003258061001395543,
            "start_logit": 3.066305637359619,
            "end_logit": -2.8157694339752197,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza",
            "probability": 0.0018660538189739452,
            "start_logit": -3.207524299621582,
            "end_logit": 2.90075421333313,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation",
            "probability": 0.0016850965238858742,
            "start_logit": 3.066305637359619,
            "end_logit": -3.475078821182251,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "A",
            "probability": 0.0015050007046225127,
            "start_logit": 3.066305637359619,
            "end_logit": -3.5881083011627197,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za",
            "probability": 0.0009253516156674346,
            "start_logit": -3.9089317321777344,
            "end_logit": 2.90075421333313,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Afrezza inhalation insulin.",
            "probability": 0.0005572650734999123,
            "start_logit": 3.066305637359619,
            "end_logit": -4.581615924835205,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "compared with Afrezza",
            "probability": 0.00011805024698408196,
            "start_logit": -5.9679951667785645,
            "end_logit": 2.90075421333313,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "intratracheal insufflation and compared with Afrezza",
            "probability": 9.777897851585328e-05,
            "start_logit": -6.15639591217041,
            "end_logit": 2.90075421333313,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins_SD",
            "probability": 8.767489354427652e-06,
            "start_logit": -1.9943078756332397,
            "end_logit": -3.6729929447174072,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza inhalation insulin",
            "probability": 6.1414297636273954e-06,
            "start_logit": -3.207524299621582,
            "end_logit": -2.8157694339752197,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins",
            "probability": 4.244299746149177e-06,
            "start_logit": -1.9943078756332397,
            "end_logit": -4.39846658706665,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "Ins_SD)",
            "probability": 3.2385162817204876e-06,
            "start_logit": -1.9943078756332397,
            "end_logit": -4.668928146362305,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza inhalation",
            "probability": 3.1763990735425057e-06,
            "start_logit": -3.207524299621582,
            "end_logit": -3.475078821182251,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za inhalation insulin",
            "probability": 3.0454544753727864e-06,
            "start_logit": -3.9089317321777344,
            "end_logit": -2.8157694339752197,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "insulin",
            "probability": 2.664443110887763e-06,
            "start_logit": -4.042586803436279,
            "end_logit": -2.8157694339752197,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "za inhalation",
            "probability": 1.5751346423241289e-06,
            "start_logit": -3.9089317321777344,
            "end_logit": -3.475078821182251,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "A novel pure insulin spray-dried powder for DPI product (Ins_SD",
            "probability": 1.1206945679868978e-06,
            "start_logit": -4.051409721374512,
            "end_logit": -3.6729929447174072,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "frezza inhalation insulin.",
            "probability": 1.0504420596042957e-06,
            "start_logit": -3.207524299621582,
            "end_logit": -4.581615924835205,
            "question_text": "Name two inhalable insulin products."
        },
        {
            "text": "spray-dried powder for DPI product (Ins_SD",
            "probability": 8.881637792285671e-07,
            "start_logit": -4.283957481384277,
            "end_logit": -3.6729929447174072,
            "question_text": "Name two inhalable insulin products."
        }
    ]
}
